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Abstract
Chronic kidney disease (CKD) is a set of pathophysiological reactions that impact the
functionality of the kidney. The association between microvascular disease (MVD) and
CKD as it relates to diabetes is important to the evaluation of organization effectiveness
in hospital services planning as well as improving health outcomes. The purpose of this
quantitative, cross-sectional study was to determine if there is an association between
MVD and CKD severity in persons with diabetes. Using the socioecological model, the
association between gender, age group, cigarette smoke, cigarette smoke frequency,
alcoholic drink, alcoholic drink frequency, hypertension, albumin-to-creatinine ratio
(ACR) severity, cholesterol, sickling (i.e. persons with sickle cell disease),and MVD was
examined. Across-sectional data analysis, using secondary data from 2013 to 2017 (N =
775) in the Grenada medical records department, was used to identify associations of
CKD status in persons with diabetes over the age of 16 years old. The relationship
between the study predictors and the outcome variable was analyzed using chi-square
tests and binomial logistic regression. The key findings showed drinking and
hypertension were the only significant predictors of CKD severity. The social change
implications of this study will not only benefit health care professionals but also the
community by assisting in the, enhancement of national guidelines and public health
policy, and the implementation of programs aimed to improving risk factors that have
been shown to reduce CKD outcomes in Grenada.
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Section 1: Foundation of the Study and Literature Review
Introduction
Microvascular disease (MVD) results in the narrowing of small vessels within the
body, impacting the functionality of the body system (Beckman, J.A., Duncan, M.S.,
Damraven, S.M., … Freiberg, M.S., 2019). The primary contributing factor of MVD is
exposure of the tissues to chronic hyperglycemia (Diabetes.co.uk, 2018). In persons with
Type 2 diabetes (T2DM), MVD has been shown to be associated with a higher risk of
macrovascular events (Mohammedi et al., 2017). Additionally, persons with T2DM that
present with MVD have an increased risk of cardiovascular morbidity and mortality when
excluding pre existing risk factors for cardiovascular disease (Brownrigg et al., 2016).
According to the Centers for Disease Control and Prevention’s (CDC; 2014b) National
Diabetes Statistics Report, MVD can be reduced through proper control of blood sugar
levels; however, left untreated, MVD can lead to various complications as it relates to
diabetes, including diabetic nephropathy, diabetic retinopathy, and diabetic neuropathy.
Nephropathy is the damaging or disease of the kidney, and in diabetic nephropathy that
damage is due to complications related to a person having diabetes (Gross, J.L., Silveiro,
S.P., Canani, L.H., Caramori, M.L., & Zelmanovitz, T.,2005). In severe cases, this can
lead to kidney failure and organ transplantation; however, kidney damage does not occur
in all cases of diabetic persons (American Diabetes Association, 2015a). Nephropathy
can lead to end stage renal disease (ESRD), which in turn can lead to persons needing
dialysis and kidney transplantation (Moore et al., 2009). The contributing factors that can
lead to ESRD include the development of hypertension and a decrease in glomerular
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function (Martínez-Maldonado, M., 1998). According to the National Institute of
Diabetes and Digestive and Kidney Diseases (2016), more than 661,000 Americans had
kidney failure and compared to Caucasians, ESRD is about 3.7 times more prevalent in
African Americans, 1.4 times greater in Native Americans, and 1.5 times higher in Asian
Americans. Retinopathy is a condition that affects the retina; decreases vision; and over
time, if left uncontrolled, can lead to blindness. In the United States, diabetic retinopathy
is one of the leading causes of blindness among 25- to 74-year-olds (CDC, 2014a;
Whitaker, 2001). Finally, a complication of MVD is neuropathy, which impacts nerves of
the individual. Among diabetic polyneuropathy persons, 20% to 30% suffer from
neuropathic pain (Tesfaye et al., 2011). Common symptoms can vary from a reduction in
pain sensations to changes in pressure sensations, which can not only lead to lower limb
injuries but also an increased risk of lower limb amputations (Hicks, C.W. & Selvin, E.,
2019).
This study was designed to look at the association between MVD and chronic
kidney disease (CKD) in persons with T2DM within Grenada. In this study, I examined
factors that influence health outcomes related to CKD, T2DM, and MVD as well as made
recommendations that may assist in improving national chronic health conditions.
Implementation of the findings of this study may improve the effectiveness of primary
health programs in Grenada because the findings provide evidence for the planning,
decision-making, and implementation of health policies. The study may also be used as a
resource for further investigation and strategic planning of other chronic disease concerns
in Grenada.
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In this section of this dissertation, I elaborate on the problem statement and clarify
the purpose of the study. This is followed by a presentation of the research questions and
hypotheses, theoretical foundations for the study, nature of the study, and literature
search strategy. The rest of the section is devoted to an extensive literature review in
which major concepts are defined; the assumptions made in the study are itemized; and
the scope, limitations, and delimitations of the study are described.
Problem Statement
CKD is a condition that does not occur in isolation(i.e., does not occur due to one
particular issue) but instead is a range of pathophysiological reactions linked to changes
in the functionality of the kidney as well as a continued decline of its glomerular filtration
rate (GFR; Ferguson et al., 2012).According to the Kidney Disease: Improving Global
Outcomes Chronic Kidney Disease Workgroup(2012) CKD is defined as when the
structure and functionality of the kidney presents this decline for more than 3 months and
impedes an individual’s health. Abnormal kidney function occurs when the GFR is less
than 60 ml/min/1.73m2 (Ferguson et al., 2012). The severity of CKD is determined by
the stage at which the disease has progressed. These stages increase in severity from
Stage 1 to Stage 5, with Stages 3–5 being considered the most dangerous and leading to
ESRD, dialysis, or even death (Thomas, R., Kanso, A., &Sedor, J.R., 2008). It is
estimated that the worldwide prevalence of CKD is between 8% and 16% and 11.5% in
the United States (Levey & Coresh, 2012). Within the Caribbean, however, the exact
prevalence and incidence of CKD and MVD are not fully known due to incomplete or
inaccurate data collection within the Organization of Eastern Caribbean States (OECS),
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which includes the countries of Grenada, Commonwealth of Dominica, Antigua, St.
Lucia, St. Vincent and the Grenadines, and St. Kitts and Nevis.
Among OECS countries, chronic noncommunicable diseases (CNCDs) continue
to plague the region (Crews et al., 2017). Non communicable diseases (NCDs), including
diabetes, stroke, CKD, heart disease, and hypertension, are among the significant
contributors to over half of deaths among members of the OECS (Caribbean
Epidemiology Centre, 2000). Per the International Diabetes Federation (IDF), the global
prevalence of diabetes mellitus (DM)is 8.3% of the population, with the Caribbean
having an overall prevalence of approximately 9%,which is responsible for 13.8% of all
adult deaths in the region (Bennett et al., 2015). The Pan American Health Organization
(PAHO) says that within the Caribbean region, DM affects an estimated 10% to 15% of
the adult population and accounts for most premature deaths (PAHO, 2012).
Persons with renal impairments (i.e., CKD Stages 3–5) not only have an increased
risk of MVD but also a higher likelihood of aortic, cerebrovascular and peripheral
vascular disease (Ooi et al., 2011). Additionally, CKD patients have an increased chance
of developing lacunar infarcts, and those over the age of 55 years old make up almost
70% of dialysis patients with varying degrees of cognition impairments that are of
microvascular origin (Soyibo, Roberts, & Barton, 2011). Persons from an AfricanCaribbean background have been found to have not only a higher prevalence of diabetes
and renal failure, but also worse overall outcomes as compared to other ethnic groups
within the United Kingdom (Brown, Avis, & Hubbard, 2007).
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Due to the increasing numbers of persons within the Caribbean having diabetes
and developing either CKD or ESRD, it is essential to see if any additional links may be
leading to these disproportionate numbers. Another link that could be evaluated, as it
relates to CKD and diabetes, is to look at the MVD. MVD is defined as an injury to small
blood vessels in the body, including capillaries, resulting in such issues as nephropathy,
retinopathy, and neuropathy (CDC, 2014a). However, there have not been studies on the
relation of MVD to CKD patients with diabetes in the region (Ezenwaka et al., 2008;
Ezenwaka et al., 2016; Graciolli et al., 2017); therefore, I conducted this study to fill the
gap in the literature.
Per the Caribbean renal registry, DM and hypertension are the leading causes of
CKD and ESRD (Soyibo et al., 2011). Although many have studied diabetes, CKD,
ESRD, and their prevalence, there has been little research conducted on MVD and its
relationship to CKD severity in individuals with diabetes, specifically in Grenada. The
extant literature includes studies specifically related complications of CKD/ESRD (i.e.,
anemia and mineral bone disease) and its related complications (i.e., obesity,
hypertension, and dyslipidemia).
Purpose of the Study
The purpose of this quantitative, exploratory study was to determine the
association between MVD and CKD severity in individuals with diabetes in Grenada. In
this study, I also sought to look at the organizational factors of the socioecological model
(SEM) of health and its impact on CKD outcomes. This was not an intervention study but
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rather an exploratory, cross-sectional study to set the groundwork for potential further
studies on CKD severity on diabetes patients on the island.
Research Questions and Hypotheses
RQ1: Is there an association between MVD and CKD severity among diabetes
patients in Grenada with or without hypertension, when controlling for age,
gender, glycated hemoglobin (A1C), body mass index (BMI), alcohol use, and
smoking?
H01: There is no statistically significant association between MVD and
CKD severity among diabetes patients in Grenada with or without
hypertension when controlling for age, gender, A1C, BMI, alcohol use,
and smoking.
HA1: There is a statistically significant association between MVD and
CKD severity among diabetes patients in Grenada with or without
hypertension when controlling for age, gender, A1C, BMI, alcohol use,
and smoking.
RQ2: What is the significance between prevalence of MVD and CKD severity
among patients in Grenada with diabetes with or without hypertension when
controlling for age, gender,A1C, BMI, alcohol use, and smoking?
H02: There is no significance between prevalence of MVD and CKD
severity among patients in Grenada with diabetes with or without
hypertension when controlling for age, gender, A1C, BMI, alcohol use,
and smoking.
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HA2: The prevalence of MVD is ≥ 50% of CKD patients in Grenada with
diabetes with or without hypertension when controlling for age, gender,
A1C, BMI, alcohol use, and smoking.
Theoretical Foundation for the Study
I used SEM as the theoretical framework of this study to explore the
environmental risk factors that may increase a person’s possible development of MVD as
it relates to CKD severity in persons with diabetes within Grenada. The SEM is a health
promotion approach that looks at some broad variables that influence health, whether for
the good or bad (Robinson, 2008). The SEM is made up of five factors: individual,
interpersonal, community, organizations, and or policy/enabling environmental factors
(Green, Richard,& Potvin, 1996; Stokols, 1996;see Figure 1). The United Nations
Children’s Fund (UNICEF) identifies these factors include individual, interpersonal,
community, organizations, and policy /enabling environmental factors. Individual factors
are an individual’s knowledge, attitudes, and behaviors that impact their health, including
but not limited to age, gender, ethnicity, and sexual orientation (UNICEF, 2009).
Interpersonal factors are the social networks and social support systems that may
influence a person’s behaviors (UNICEF, 2009). Community factors are the association
among the organizations and informational networks within a specific location, including
the local environment, villages, community leaders, and businesses (UNICEF, 2009).
Organizational factors are those that impact the effectiveness of services provided and
may hinder the health of a group or individual (UNICEF, 2009). Finally, policy/enabling
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environmental factors are local, state, national, and international laws and policies that
impact the health of an individual or a group of persons (CDC, n.d.; UNICEF, 2009).

Figure 1.Social ecological model diagram. Source:
http://www.cdc.gov/violenceprevention/overview/social-ecologicalmodel.html

In this dissertation, I focused on the organizational factors of the SEM. The
organizational factors (i.e., the rules, regulations, policies, and informal structures) can
either promote or constrain health behaviors (Robinson, 2008). By understanding the
current health situation related to MVD, CKD, and diabetes among the Grenadian
population, along with the health organizational structure within the country, the
groundwork for improving the healthcare system can be better laid. Using this factor of
the SEM in this study, helped me better understand any potential organizational barriers
to the treatment and life expectancy variation between persons in Grenada with this
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disease as compared to the Western world. I conducted this study through the collection
of secondary data, mainly mortality and morbidity rates of persons living with CKD and
diabetes and compared these rates to those with MVD along with CKD and diabetes.
Collecting and comparing this information as well as information related to the cost of
services, cost of living, and the availability of specialists related to this disease provided
the groundwork for future work in developing policies and educational assistance for
healthcare professionals to decrease the mortality and morbidity rates as it relates to this
disease. The findings of this study also have the potential to provide much-needed
information on health promotion initiatives as well as for the continued education of
medical staff and the procurement of any needed specialists for this field.
Nature of the Study
I used a quantitative, cross-sectional design to MVD to CKD severity in
individuals with diabetes among Grenadians. The secondary data used in this analysis
came from the sampling of 2016 medical records. In-depth interviews, questionnaires,
and focused groups were not used in this study because the primary focus was on the
potential severity of this CNCD in Grenada. The independent variables in the study were
MVD and diabetes, the dependent variable was CKD severity, and the controls were age,
gender, smoking, and weight.
Literature Search Strategy
I used the following databases to locate literature for this study: Walden
University Library and Walden Library Books, PubMed, CINAHL Plus with Full Text,
MEDLINE with Full Text, Dissertations & Theses, and Dissertations& Theses at Walden
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University, ProQuest Central, Science Journals, and Science Direct. Good Scholar,
Google, Walden Library Search, World Health Organization (WHO), UNICEF, PubMed,
and ProQuest search engines were also used. The following keyword search terms were
used: Type 2 diabetes, diabetes mellitus, CKD, chronic kidney disease, microvascular
disease, risks for microvascular disease, Caribbean, risks for CKD, diabetes in Grenada,
CKD in the Caribbean, social ecological model, IDF, UNICEF report, WHO report,
NDHS, SEM, and CDC reports.
Although I had an open-ended search for literature, emphasis was placed on
publications spanning a period of 5 years (i.e., 2013–2018) for this study. I also placed
emphasis on peer-reviewed primary publications within the period under review. In
addition, national documents, WHO, CDC, and UNICEF periodicals and reports were
used to augment the literature review. Some seminal literature like that on the SEM as
well as some critical publications on prevalence of CKD, diabetes, and its related risk
factors within the Caribbean region was used. Finally, a few doctoral studies and
dissertations from the Walden University Library were also reviewed.
Literature Review Related to Key Variables and/or Concepts
Population
According to the Index Muni (2018), as of 2017, it is estimated the population of
Grenada to be about 111,724, with 24% being less than 15 years of age, just 10% over the
age of 65, and a median age of 31.5 years. Of this, 35.7% lived in urban communities; the
total sex ratio of male to females is 1.03, and as of 2016, a birth rate of 15.5 per 1,000
population and 9.7 deaths per 1,000 live births per year (Index Muni, 2018). With a gross
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national income per capita of $14,700, Grenada spends about 6.1% of the gross domestic
product on health (Central Intelligence Agency, 2017; WHO, 2015). Grenadians have a
life expectancy at birth for males and females of 71 and 76 years old, respectively (WHO,
2015).
Grenada has about five different ethnic groups who speak roughly five different
languages and dialect; however, English is the official language with French Patois,
Spanish, Mandarin, and Indian Hindi being the dominant local languages (Central
Intelligence Agency, 2017). Christianity is the predominant religious belief, with some
being Roman Catholic and the majority being Protestant (The World Factbook, 2018).
According to Health Grove (2013b), the annual mortality rate per 100,000 persons
related to DM increased by 57.5% in Grenada since 1990. From 2005 to 2016, the
incidence of diabetes dropped by 2.7% from 2005 to 2016; however, it not only remains
the third leading cause of death in the country but also the third leading cause of
premature deaths with an increase of 0.4% during the same period (Institute for Health
Metrics and Evaluation, 2016). However, CKD is the leading cause of disability-adjusted
life years and the fifth leading cause of death in 2016 (Institute for Health Metrics and
Evaluation, 2016).
Physiology of Chronic Kidney Disease
CKD is characterized as a condition that damages the kidneys and decreases its
functionality (National Kidney Foundation, 2017). CKD can be quantified by a high
measure of the GFR for more than 3 months (Thomas, Kanso, &Sedor, 2008). According
to the U.S. National Kidney Foundation, Kidney Disease Outcomes Quality Initiative,
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CKD is defined as damage to the kidney or GFR lower than 60 ml/min per 1.73 m2 for 3
months or longer (Jha et al., 2013). The main contributors to CKD in individuals are
diabetes and hypertension; however, any health condition that damages the kidneys can
lead to CKD (CKD, 2019). Within the Caribbean, as of 2013, the significant risk factors
for CKD include low GFRs, high systolic blood pressure, high fasting plasma glucose,
high body mass index, and dietary risks (Health Grove, 2013a). This CNCD is a global
issue impacting persons from all income levels and various income countries; however,
the incidence, prevalence, and progression of CKD vary per country (Webster, Nagler,
Morton, & Masson, 2016). Per Health Grove (2013a), the annual mortality rate for CKD
within the Caribbean is 18.39 per 100,000 people, which is an 87.1% increase from 1990.
The kidney is a vital organ within the body. Some of the functions of the kidney
include: “excretion of waste, acid-base regulation, body water and electrolytes,
detoxify/metabolize drugs/hormones, regulate blood pressure and endocrine system”
(Gattone, 2007, A-2 ). Due to the gradual progression of kidney deterioration, many
persons are asymptomatic until kidney damage irreversible (Pradeep, A.M., 2020).As the
kidney begins to decline in functionality; complications can lead from CKD to ESRD
(Thomas et al., 2008). When this begins to occur, it is classified by way of the National
Kidney Foundation’s Kidney Disease Outcomes Quality Initiative from Stage 1 to Stage
5. The premise of Kidney Disease Outcomes Quality Initiative is to establish guidelines
for establishing universal best practices for clinical kidney disease, including (a) defining
CKD and classify its stages despite its underlying cause, (b) evaluating laboratory
measurements of assessing clinical kidney disease, (c) associating kidney function levels
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with CKD complications, and (d) determining risk of kidney loss of function and the
development of cardiovascular disease (Levey et al., 2003). These stages are clinically
defined by laboratory evaluations as follows: Stage 1-normal eGFR ≥90 mL/min per
1.73m2; Stage 2- eGFR between 60 to 89 mL/min per 1.73m2; Stage 3- eGFR between
30 to 59 mL/min per 1.73 m2; Stage 4- EGFR between 15 to 29 mL/min per 1.73 m2 ; and
Stage 5- EGFR of <15 mL/min per 1.73m2 or ESRD (Chapter 1: Definition and
classification of CKD,2013).
Physiology of Diabetes
DM orT2DMis a metabolic disorder characterized by the ineffective distribution
of insulin within the body, also known as hyperglycemia (American Diabetes
Association, 2013). Insulin, the energy vehicle within the body that moves sugar into the
cells, is produced in the pancreas (Cologne, Germany: Institute for Quality and efficiency
in health care, 2018).When the pancreas begins to have difficulty accurately producing
insulin, it can lead to Type 1 diabetes, or juvenile diabetes, which is more commonly
found in children (Fonseca, 2006). In contrast, in T2DM, the body has sufficient insulin
in the body but is not able to utilize it efficiently to lower the blood glucose levels
(Fonseca, 2006).Where T2DM deals with the utilization of insulin in the body, Type 1
diabetes deals with the lack ofa deficiency of insulin, usually occurring within children
(American Diabetes Association, 2009). Another form of diabetes can occur during
pregnancy, which can increase a woman’s chances of developing T2DM later in life
(Kim, Newton, &Knopp, 2002). In this study, I focused on T2DM.
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Persons that are diagnosed with diabetes are usually of increased age,
overweight/obese, and with decreased physical activity; genetics also can play a
significant role in the development of diabetes (Pulgaron, E.R. & Delamater, A.M.,
2014). The bodies’ inability to efficiently utilize insulin within the cells is known as
insulin resistance (Wilcox, G., 2005). Insulin resistance has been said to be responsible
for health concerns, including obesity, hypertension, triglyceride and cholesterol
abnormalities, polycystic ovarian syndrome, and increased heart disease risk (Whitaker,
2001). T2DM left untreated or managed can lead to hyperglycemia, resulting in the most
diabetic-related physical complications (Ramteke, P., Deb, A., Shepal, V., & Bhat, M.K.,
2019). This increased level of glucose within the body leads to a build-up of sorbitol,
which has been shown to be linked to nerve and eye damage (Whitaker, 2001).
Unfortunately, this form of diabetes is many times left untreated for years, and when
discovered, the person has extremely high blood glucose levels; nerve, eye, and kidney
damage, and other organs may have been compromised (Department of Health and
Human Services, 2015). All of this damage could be mitigated through either a fasting
blood glucose test, which looks at the amount of glucose in an individual’s body when
fasting for 8 hour or an A1C test, which looks glucose average within a 3-month period
(Sherwani, S.I., Khan, H.A., Ekhzaimy, A., Masood, A., & Sakharkar, M.K., 2016 ). A
diagnostic fasting blood glucose reading of 70–110 mg/dl is within reasonable limits, and
values great than 126 mg/dl can suggest a person has diabetes, which would be followed
up with an A1C test for confirmation(American Diabetes Association, 2016). Gaining a
better understanding of the physiology of diabetes and its contributing factors will not

15
only reduce the risk of developing diabetes but also decrease its prevalence within the
region and around the world.
Prevalence of Type 2 Diabetes
As of 2015, 30.3 million or 9.4% of people in the United States are diagnosed
with diabetes, and of these, 7.2 million are undiagnosed or unaware they have diabetes
(ADA, 2015b). Globally, there has been an increase in diabetes from 108 million or 4.7%
in 1980 to 422 million or 8.5% as of 2014, indicating that diabetes has become an
increasing global threat both to individuals as well as health systems (WHO, 2017). It is
estimated that by 2030, the world prevalence of diabetes will increase from 6.4% of the
population or 285 million adults from 2010 to 7.7% or 439 million by 2030 (Shaw, J.E.,
Sicree, R.A., &Zimmet, P.Z., 2010). Fonseca (2006) estimated that by 2050, the number
of people in the United States diagnosed with diabetes will be 39 million (a 225%
increase) and prevalence between 4.4% to 9.7% (a 120% increase from previous
estimates). The diabetes prevalence increase has affected 69% of developing countries
and 20% of developed countries (Shaw, Sicree, &Zimmet, 2010).It is also estimated that
over 70% of cases in the next 20 years will come from developing countries, with most
persons affected being between the ages of 45 and64 years old (Wild, Roglic, Green,
Sicree, & King, 2004).According to the Macro Economy Meter (2013),Grenada is ranked
61st as it relates to diabetes and the prevalence of diabetes for populations aged 20 to 79
years is 9.44% as compared to countries such as Bosnia and Herzegovina, Portugal,
Sudan, Iraq, Chile, Tunisia, Cyprus, Brazil, South Africa, and the United States.
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Some of the major influencers on the increase of diabetes prevalence are an
increasingly aging population among seniors 65 years and older, ethnicity, family history,
being obese, socioeconomic status, increased age, sedentary lifestyles, place of residence,
and having diets rich in fats; these factors have been shown to increase the prevalence of
diabetes both in the U.S. and around the world (ADA, 2013; CDC, 2013; Jain & Saraf,
2010). According to the CDC (2012a), an estimated 25.9% or 12 million of seniors in the
United States have T2DM. Ethnic groups are the hardest affected by T2DM and seem to
have a higher predisposition to the development of this disease. The ethnic groups in the
United States most impacted are American Indians/Alaska Natives (15%), Asian
Americans (9.0%), non-Hispanic Blacks (13.2%), and Hispanic Americans (12.8%) as
compared to Non-Hispanic Whites(7.6%;CDC, 2014a). Within the Caribbean, it has been
found that there is a higher prevalence of diabetes among adult Black populations,
affecting about 1 in 5 persons, and increasing morbidity and mortality rates (Hennis et al.,
2002).
Prevalence of Chronic Kidney Disease
As industrialization has changed the face of the known world, there has been a
shift in the focus of the health field from infectious diseases to CNCDs. One such change
includes the leading causes of morality. Diseases of the kidney, overtime, have not only
become a leading contributor of mortality rates but also are steadily reaching epidemic
magnitudes within first-world countries (Eknoyan et al., 2004). It is estimated that 8%–
16% of persons in the world are affected by CKD (Jha et al., 2013).According to the
2010 Global Burden Disease study, in 1990 CKD was ranked 27thon the list of causes for
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the total number of global deaths; however, its ranking had increased to 18th in 2010 with
an annual death rate of 16.3 per 100,000 (Lozano et al., 2013). Kidney disease is
attributed to more deaths than prostate or breast cancer, and in 2013, it was reported that
more than 47,000 Americans died from it (Xu, Murphy, Kochanek, &Bastain, 2013).
Within the United States, CKD occurs in 14% of the general population (NIDDK, 2016).
The NIDDK (2016) found that more than 661,000 Americans currently have kidney
failure, of which 468,000 are on dialysis, and an estimated 193,000 are living with
operational kidney transplants.
Though within the United States CKD can affect anyone, it does not impact each
race equally. The CDC (2012b) found that African Americans (17.01%) and Mexican
Americans (15.29%) were more likely to have CKD than European Americans (13.99%).
Not only is there a variation in prevalence among races but also by gender. Women are
more likely to be diagnosed with CKD Stages 1–4 then men, 15.93% and 13.52%,
respectively (CDC, 2012b).
Additional factors that may influence the prevalence of CKD are the following
four main risk factors: susceptibility, initiation, progression, and end-stage (Taal, M.W.
& Brenner, B.M., 2006). Susceptibility factors are those factors that increase a person’s
chances of developing kidney damage; this includes older age, family history, reduction
of kidney mass, low birth weight, low income or education, and ethnicity (Levey et al.,
2003). The second factor, initiation factors, are those that directly start the process of
kidney damage, would include diabetes, high blood pressure (BP), autoimmune diseases,
systemic infections, urinary tract infections, urinary stones, lower urinary tract
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obstruction, or drug toxicity (Levey et al., 2003). The third contributing factor is a
progression of the disease; these are causes that worsen the kidney damage and factors
that decrease the functionality of the kidney after the commencement of kidney damage,
some examples include high BP, poor glycemic control in diabetes, smoking, and
elevated protein urea (Levey et al., 2003). Finally, end-stage factors are those that
increase persons’ morbidity and mortality rate within kidney failure; this would include
low dialysis dose, late referral to care, low serum albumin levels, anemia, or temporary
vascular access (Levey et al., 2003). However, little is known about the actual prevalence
of CKD within the Caribbean.
Risk Factors for Type 2 Diabetes
The prevalence of T2DM in North America and the Caribbean is estimated at
12.9% (IDF, 2015). Within Grenada, the national prevalence of diabetes among adults is
10.3% of persons age 20-79, which is 6.9 in every 1,000 persons (IDF, 2015). There is a
multitude of various factors that have been found to contribute to the development of
T2DM. Per the CDC (2012a) persons having a low socio-economic status (SES) have a
higher risk of developing T2DM than those of higher economic status. A major
contributing risk factor to its development is family history (Cheng et al., 2012). Studies
have shown that even when factoring in socioeconomic and behavioral factors, Blacks
were twice as more likely to develop T2DM than their White counterparts (Brancati et
al., 2000). As the level of education decreases, as well as income and SES, there was
found to be an increased risk of T2DM, according to the prospective Black Women’s
Health Study (Krishnan et al., 2010). Studies have also shown that there is a link between
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low SES and increased T2DM. The potential reasons for this link include lack of
resources, diminished accesses to healthcare, lower levels of income, education and
physical inactivity, and postponement of medical care and inadequate dietary options
within available income (Robbins, Vaccarino, Zhang, &Kasl, 2005; Williams & Jackson,
2005).Alternatively, as education and income increased the same study found no
difference in the development of T2DM among women (Conen et al., 2011). Another
contributing risk factor would obesity and weight of the individual. These findings were
challenged by a study by Lee et al. (2011), which found that low SES was not responding
to the increased rate of T2DM among the African American community. In short, a
person’s increase of education and income did not prevent their development of diabetes.
These risk factors may have been found to contribute to the risk of development of
T2DM, but it is not always quite that simple.
According to a study by the United States Agency for International Development
(USAID) in collaboration with Johns Hopkins School of Public Health, within the Latin
American and Caribbean (LAC) region about half of all years lost to life are attributed to
NCDs (Anderson et al., 2009). Among Black Barbados Caribbean nationals, there is a
noticeably high prevalence of diabetes as compared to other ethnic groups within the
country, affecting an estimated 1 in 5 people and increasing mortality and morbidity rates
(Henniset al., 2002). The issues of diabetes and its related factors, as it relates to the
prevalence of diabetes, vary by ethnic group. Of those who knew their status, 17.5%
impacted were Black, 12.5% mixed race, and 6.0% White (Hennis et al., 2002). Adult
Black populations are disproportionately negatively affected by diabetes than other ethnic
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Caribbean groups. An estimated 1 in 5 Black adults are at risk for diabetes and have
increased levels morbidity and mortality (Hennis et al., 2002). Additional risk factors
include age, diabetes history, hypertension, high BMI and weight to height ratios,
increased education and the level of alcohol consumption.
Caribbean Blacks and Chronic Kidney Disease
NCDs account for sixty-six percent (66%) of the health burden within Latin
America and the Caribbean (LAC), this includes diabetes, CKD, cardiovascular disease,
respiratory and digestive diseases (Anderson et al., 2009). Among the LAC, the top eight
countries that have the highest percentages of years of life lost due to NCDs as compared
to the percentages associated with communicable disease are Netherlands Antilles (85%),
Cuba (73%), Uruguay (72%), Antigua (69%), Dominica (68%), Antigua and Barbuda
(66%), Grenada (66%), and Jamaica (66%), (Anderson et al., 2009).Globally, as well as
within the Caribbean, the major contributor to CKD and ESRD are chronic lifestylerelated disease, i.e., DM and hypertension (Soyibo, Roberts, & Barton, 2011; Moeller,
Gioberge, & Brown, 2001; Soyibo& Barton, 2007). Worldwide, treatment for ESRD
continues to grow at 5times the population growth rate of 1.3% (Moeller, Gioberge, &
Brown, 2002). CKD is a significant concern within the Caribbean due to many financial
challenges. Renal replacement therapy (RRT), currently is not available in all Caribbean
countries and cases they are available, the leading form of modality is hemodialysis
(Soyibo et al., 2011). Within the Black American community contributing factors that
lead to T2DM and CKD include low SES, race, poverty, obesity, inappropriate diet, low
levels of physical activity, decreased income levels and lowered educations (Krishnan et
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al., 2010). Soyibo et al. (2011) found however that within the Caribbean some CKD
contributing factors include not only these factors but also lack of BP management,
uncontrolled glucose, married with lifestyle modifications, and nutrition, if controlled,
could reduce the increasing burden of renal failure in the region.
It is these risks factors that contribute to the increase of CKD and diabetes
complications within the Caribbean. Persons with CKD have not only high healthcare
utilization rates but also mortality and morbidity rates as well (Thorp, Eastman, Smith,
&Johnson, 2006). The prevalence and incidence of CKD through the entire Caribbean is
currently unknown, but information is known for some more substantial islands such as
Jamaica and St. Kitts. In a study by Ferguson et al. (2015), it was found that among
persons attending a specialist diabetes clinic within Jamaica of the 132 participants of the
study, 86.3% had not only diabetes but also CKD. Additionally, it was found that the
longer a person had diabetes was associated with CKD (Ferguson et al., 2015).
Current literature has been minimal in providing a clear and detailed look at the
extent of CKD within the region. However minimal the information is there continuing to
be a growing understanding and accesses to services for treatment has continued to
improve over the years. Some countries have been more successful in providing
necessary care and treatment within the country to their citizens, such as Grenada,
Jamaica, Trinidad, and Barbados, but there remains continued effort to improve the
standard of conditions and services as it relates to CNCDs within the region.
Additionally, as prevention education increases and improves and the focus of
encouraging persons to improve lifestyle choices, the number of CKD related deaths will
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begin to improve. To achieve such goals, there needs to be a reduction in the incidence of
CKD, slow ESRD progression which leads to the need for RRT and provide more
efficient financial options for RRT (Soyibo et al., 2011).
Microvascular Complications
Diabetes-related complications include retinopathy, neuropathy, and nephropathy,
which can lead to various adverse outcomes, including blindness, amputations of the
lower limb and kidney failure (Moore, Gregory, Kumah-Crystal, & Simmons, 2009).
Retinopathy occurs due to small vessels of the retina becoming damage due to
uncontrolled blood sugar levels, leading to impaired vision and blindness in many cases.
According to PAHOs Strategic Framework Visions 2020: The Right to Sight, within the
Caribbean Region, more than 75% of persons diagnosed with DM for over 20 years will
develop some form of diabetic related retinopathy, 10% will develop severe visual
impairments, and about 2% will become blind. Additional contributors to retinopathy
include high blood pressure and cholesterol. Nephropathy, when left untreated or poorly
managed, can lead to ESRD, thus requiring either dialysis and organ transplant (Moore et
al., 2009). The exact global impact of ESRD within the region is unknown. However, the
WHO estimates the death burden to more than 400, 000 per year, as compared to 300,000
in the 1995 Global Burden of Disease report (King, Roglic, Lozano, &Boshi-Pinto, 2001;
Murray & Lopez, 2000).
The complications related to microvascular disease, as it relates to diabetes,
include nephropathy which leads to renal failure, retinopathy – which can lead to
blindness, and neuropathy – which can lead to lower limb amputations (Moore et al.,
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2009). The best way to reduce a person’s risk of developing microvascular disease
complications is to have blood sugar under control (CDC, 2014b). Nephropathy is a
disease affecting the kidneys which can lead to CKD or ESRD thus requiring dialysis or
organ transplant (Moor et al., 2009). As patients become hypertensive and kidney
function decrease the risk of developing renal failure increases.
In 2014, diabetes was described as the primary cause of 52,000 people developing
ESRD (CDC, 2017). Unfortunately, due to health disparities, some ethnic groups are
more impacted by this disease than other. Within the United States, non-Hispanic Blacks
(9.0 per 1,000 persons) and Hispanics (8.4 per 1,000 persons) have a higher age-adjusted
incidence of diabetes than their non-Hispanic White counterparts (5.7 per 1,000) (CDC,
2017). Furthermore, persons within the Caribbean, the mortality rate due to CKD, was
higher in 2013 for the region as compared to the world average, i.e., 18.4 and 13.3 per
100,000 people, respectively (Health Grove, 2013). Retinopathy is a destruction of the
retina and nerve endings impacting ones’ vision that can lead to blindness. The leading
cause of blindness among 25 to 74-year olds in America is due to diabetic retinopathy
(CDC, 2014b; Whitaker, 2001). According to PAHO and WHO strategic Framework
vision 2020: The right to Sight report, diabetic eye disease is extensive in the Caribbean.
With more than 75% of diabetic persons who have had the disease for more than 20 years
develop some form of diabetic retinopathy.
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Operational Definitions
Acute renal failure: traditionally defined as the rapid fall of the which clinically
manifests as the abrupt and continued increase in the serum levels of urea and creatinine
in association with disruption of salt and water homeostasis.
Anemia: is the reduction of one or more primary red blood cell measurements,
i.e., hemoglobin concentration, red blood cell count or hematocrit (Thomas, Kanso &
Sedor, 2008).
Body-Mass-Index (BMI): is determined by dividing a person’s weight (in
kilograms) by the square of their height in meters. (WHO, 2018).
Chronic kidney disease (CKD): abnormalities of kidney structure or function,
present for >3 months, with implications for health (N.D., 2013). Compilation of diseases
related to the decline of the kidney and its functions. A slow and progressive loss of
kidney function over a period of years resulting in the need for dialysis or kidney
transplant to maintain life (Tonelli, 2006).
Chronic noncommunicable disease (CNCD): These are diseases of long duration
and slow in progressions that are results of not only genetic but also physiological,
environmental and behavioral factors (WHO, 2017). Examples of CNCDs include, but
not limited to, cardiovascular diseases, cancers, chronic respiratory diseases, and
diabetes.
Diabetes mellitus (DM; i.e., Type 2 diabetes, T2DM): A condition where the cells
no longer can efficiently use blood sugar (glucose) for energy. T2DM occurs when the
body’s cells become insensitive to insulin and blood sugar (Oberg, Balentine, Cunha,
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&Shiel Jr., 2017). Insulin sensitivity results in consistently chronic high blood glucose
number above average range (ADA, 2013).
Dialysis: the process of removing blood from an artery, purifying it, adding vital
substances and returning it to a vein (Dialysis, n.d.)
Dyslipidemia: is a metabolic abnormality leading to a persistent increase in the
plasmatic concentration of cholesterol and triglycerides (Moor et al., 2017).
End stage renal disease ESRD: Is the last stage of chronic kidney disease (stage
5), this results in the need for either dialysis or a kidney transplant (Thomas, Kanso,
&Sedor, 2008).
Hyperglycemia: Another name for high blood sugar, is clinically defined as blood
glucose levels greater than 7.0 mmol/L (126 mg/dl) when fasting or a blood glucose level
higher than 11.0 mmol/L (200 mg/dl) 2 hours after meals (Diabetes CO.UK, 2018).
Hypertension: When the systolic blood pressure readings are higher than 140, and
diastolic blood pressure is higher than 90 due to thickening of arteries (CDC, 2014).
Hypertension is a long-term medical condition in which the blood pressure ithe arteries
remains elevated for an extended amount of time.
Incidence: measures the rate of occurrence of a new case of condition or disease
(Roe & Doll, 2000)
Insulin: Wilcox (2005) defines insulin as, “a peptide hormone secreted by the β
cells of the pancreatic islets of Langerhans and maintains normal blood glucose levels by
facilitating cellular glucose uptake, regulating carbohydrate, lipid and protein metabolism
and promoting cell division and growth through its mitogenic effects.”
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Lacunar infarcts: small infarcts (2-20 mm in diameter) located in deep cerebral
white matter, basal ganglia or pons; thought to a result of occlusion of a single small
perforating artery supplying sub cortical areas of the brain (Wardlaw, 2004).
Macrovascular disease (MVD): the disease of the large blood vessels, this
includes the coronary arteries, aorta, and large arteries of the brain and limbs
(Macrovascular disease, n.d.).
Microvascular disease (MVD): is the presence of retinopathy and lower extremity
numbness and or amputation. Diseases are resulting from poor control of blood sugar
(hyperglycemia) resulting in injury to small blood vessels which can lead to such
conditions as retinopathy, neuropathy, and nephropathy (CDC, 2014a).
Mineral bone disease: commonly occurring in persons with CKD, occurs when
damaged kidneys and abnormal hormone levels cause calcium and phosphorus levels to
become out of balanced in the blood (n.d., 2015)
Nephropathy: is defined by macroalbuminuria or a urinary albumin excretion of
more than 300 mg in 24 hr. collection. It is often characterized by a progressive increase
in protein urea and decline in GFR, hypertension and a high risk of cardiovascular
morbidity and mortality (Butt, Hall, &Nurko, 2010).
Obesity: Obesity is the excessive or abnormal build up of fat that presents a risk
to a person’s health (WHO, 2018). A person with a body-mass-index (BMI) of greater
than 30 is considered obese.
Prevalence: The overall number of persons living with a disease. (CDC, 2014a).
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Risk factors: Factors that create or contribute to the development of a disease or
leads to the increased decline of the disease condition (CDC, 2014a).
Assumptions
The following assumptions were made in this study.


Medical files documented microvascular disease accurately.



CKD severity level is clearly identified in all microvascular disease cases.



Data were entered in efficient and effective manner with minimal errors.



No bias was introduced in the study due to the random occurrence of missing
data.



The expected dependent and independent variables were contained in the
secondary data set identified for this study.



The manners of the data voluntarily released the data set for this analysis upon
request.



Dataset had enough cases and variable for unbiased study of the variables of
interest

Considering these assumptions enhanced the validity of the study.
Limitations
The following limitations of this study are hereby acknowledged:


This study was a secondary data analysis, thus some variables that may have
added value to the study were not be in the dataset.



Missing data may have affected the inferences drawn from this study and the
researcher could not modify the dataset to ensure no missing data
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This dataset was collected more than 2years prior to the study and the current
reality on ground in Grenada may have changed markedly.



The quality of the data set is dependent on the researchers and field workers
who collected the primary data, the statisticians and data clerks who inputted
the data, and the capacity of the staff who oversee the data set at the records
department in Grenada.



The quality of the data set may have been affected by the level of data
collection standards and regulations set by the Ministry of Health in Grenada
the various manipulations of the data set over the past 2 years.
Scope and Delimitations

This study is based on 2016 Grenada General Hospital medical records of CKD
patients and the socioecological factors that influence associations of MVD among CKD
patients with T2DM in Grenada. There was no contact with study participants or primary
data collected. There was a difference in time from when the information was collected
and when the secondary data analysis was taken place.
The delimitations of this study include:


This study was delimited to quantitative cross-sectional descriptive study.



It was use entirely secondary data no primary data will be gathered.



The study was delimited to the variables present in the dataset selected for this
study.



The study was also delimited to the information collected by the data
collectors.
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The study was delimited by time of data collection during patient clinical
visits to the general hospital from 01/01/2016 to 12/31/2017.
Significance of the Study and Potential for Social Change

The purpose of this study was to determine if there is an association between
microvascular disease and CKD severity in persons with diabetes evaluate the prevalence
of MVD and how it relates to CKD severity in individuals with diabetes, in Grenada,
West Indies. This project will be unique in that it will be the first of its kind within the
region to look at diabetes from a pathophysiological level as well as its potential
relationship to CKD about such matters of diabetic neuropathy and diabetic lowerextremity amputations. The results of this study will provide much-needed insight into
the impact of MVD not only among the CKD and diabetic community but also on the
healthcare system overall.
This study will provide the potential for valuable insights into the overall
knowledge of microvascular disease as it relates to CKD and T2DM, especially in this
population. This study aims to close the gap in the literature about the understanding of
the potential link between microvascular disease and CKD among Grenadian. Within the
last 5years, that has only a few studies on CKD and diabetes within the Caribbean,
including St. Lucia. This study adds to these findings and could provide the basis for
innovations, and strategic planning for interventions for the improved management of
CKD, and prevention initiatives. Several studies have shown the prevalence of CKD and
diabetes within the Caribbean and Grenada. However, no quantitative study was found
that explores the potential relationship between MVD and these diseases within Grenada.
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It also has the potential to improve how medical reports are documented as it relates to
documentation of critical medical conditions.
This study has three potential implications for social change. (a) knowledge of
CKD complications as it relates to diabetic patients. This finding has the potential to
identify the extent of this health issue within the country. Currently, within the
Caribbean, there is much knowledge about diabetes and growing community knowledge
about kidney disease, but the extent to which CKD impacts communities is still unknown
(b). Determine the relationship between MVD and CKD in persons with diabetes. These
findings have the potential for the development of policy changes in how reporting is
done as it relates to microvascular disease and CKD in diabetic patients. (c) Lifestyle
modification recommendations are another potential social change that can set the
groundwork for reducing the impact of these diseases on the country. No research is
currently available as it relates to the overall cost of MVD within Grenada. However, it
serves as a potential topic of study through grant funding.
Summary and Conclusions
This section I elaborately described the problems related to exploring the link
between MVD and CKD severity among T2DM patients and provided some background
into the topic of MVD and its various contributing factors. Additionally, the purpose of
the study, the nature of the study, the research questions and hypothesis, a detailed
literature review with emphasis on limitations, delimitations and assumptions were given.
The section ended with a description of the social change impact of the study. Section 2
focused on the methodology to be used for this investigation. This section will include a
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description of the population to be studied, the dataset used, an elaboration of the data
management processes, and the potential ethical issues and threats to validity for this
study.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this quantitative, cross-sectional study was to determine if there is
an association between MVD and CKD severity in persons with diabetes and to evaluate
the prevalence of MVD. In the previous section, I provided background on the topic,
described the problems related to exploring the link between MVD and CKD severity
among T2DM patients, the research questions, a detailed literature review, and the study
implications to social change. In this section, the study design, methodology, the nature
of the study, the operational variables, ethical considerations, and data management
processes are described.
Research Design and Rationale
In this study, after reviewing various study designs by Creswell (2009), I decided
to use the descriptive, retrospective, cross-sectional study design. The data were collected
from the medical records department from 2013 to 2017. Using secondary data not only
saved time but was also more cost effective than doing primary data collection. Although,
many datasets require an access fee, the data were already collected which reduced the
time of collecting data as compared to primary data collection and analysis, reducing
duplication (Cheng & Phillips, 2014). Additionally, using secondary data minimizes
potential ethical issues that are more commonly associated with primary data collection,
increasing confidentiality of patient information (Yiannakoulias, 2011).
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Methodology
In this subsection, I provide a description of how the study was carried out. The
subsection includes a discussion of the study area/population, secondary data
management processes, sampling techniques, and sample size.
Study Area
Grenada is a tri-island country (i.e., Grenada, Carriacou, and Petite Martinique)
made up of seven parishes and has population of over 100,000 and a median age of 33.3
years old (The World Factbook, 2020). There is one government parliament with the
parishes being divided into 15 constituencies that are governed by elected party officials
(The World Factbook, 2020). For this study, the data were obtained from the hospital,
which serves persons from each constituency. I obtained sample data from the medical
record department to capture all persons who may qualify for the study who receive CKD
and diabetes treatment.
Secondary Data Set Management
I used the hospital medical records as the secondary data set in this study.
Approval for the study was sought from the ministry of health who are the owners and
holders of the medical records. Their approval allowed me not only access to the data for
study but also potentially the ability to publish findings at the end of the study (see
Appendix A). I received official approvals from the Walden University Institutional
Review Board (IRB), and the Government of Grenada. Once this was confirmed, a
descriptive analysis was run to better confirm its accuracy and identify any missing data
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and outliers (see Green &Salkind, 2014). See Figure 1 for the data management
processes.

Identification of Data Source

Request for data set

Retrieval and review of data set

Figure 2. Data management processes.
Sampling and Sampling Procedures
The country of Grenada is a moderately sized country population with many
persons using the general hospital. This allowed for ease of conducting a randomized
sample of the study participants for the purpose of a statistically appropriate
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representation of the population. In this study, I employed a simple random sampling
technique. The simple randomization of the cases was appropriate in addressing the
research questions and subsequent variables. The benefit of using this sampling technique
is that it provides an unbiased representation of the population group studied.
Inclusion and Exclusion Criteria
In this study, the participants included individuals of all sexes above the age of 16
years old, whether visitors, permanent residents, or citizens within the tri-island country.
This decision was made to ensure that there was a large enough sample size and to reduce
any potential selection bias to the study. Persons that do not have CKD and/or T2DM
were excluded from the study. These exclusion criteria were included because the
purpose of the study was to determine the association between MVD and CKD in persons
with diabetes in Grenada.
Data Collection Tools
I used medical records from the hospital for this study. The dataset holders were
asked for access and permission to review the medical record archives. This application
for access and permission was requested to the appropriate persons who had the
authorization to release the medical records. The data set holders approved my request.
I gathered data on the independent variables of interest, such as age, sex, A1C
level, alcohol, and BP at time of study, from the medical chart and BMI was re-coded to
establish categories for the use of binomial logistic regression analysis. The dependent
variable was CKD Stages3 through 5, so I could establish the severity of the disease in
comparison to diabetes and the potential association to MVD.
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Quality Assurance and Control
I ensured the quality of the study using the data set analysis tool, Statistical
Package for the Social Sciences (SPSS), Version 25 (see IBM Corp, 2012). Outliers,
missing data, and errors in the consistency of the data set were established through
preliminary descriptive analyses. I carried out continued reviews of the data set to ensure
the variables and data collected was within the scope of the study parameters.
Procedures for Gaining Access to the Data Set
I contacted the medical records department at the hospital about the procedures
for obtaining access to medical records for research on topic. Next, I spoke to the senior
medical officer and the general hospital nephrologist about my interest and intent to do
this study. I was instructed on the best way to gain access to data on the variables of
interest in the study would be to evaluate the files of those who had kidney disease and
then identify diabetes and then look for any associations. Before using the secondary
data, particularly medical records, from another country, I obtained IRB approval from
Walden University (IRB Approval # 10-12-18-0599663) as well as study approval from
the Ministry of Health in Grenada. I waited for approval from the dataset holders, which
came a few days to weeks later with specific instructions on where to access the data,
what to do with it, and what to do with the report/publications that may result from the
analysis.
With the permission in hand, I began accessing the medical records; saved data
set variables to my password-protected, portable hard drive; and began analysis. First, I
reviewed both the data dictionary and the dataset to ensure that all the required variables
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for the study were in the set. Once this was confirmed, I ran a univariate, descriptive
analysis to have a better understanding of the data (i.e., the accuracy, skewness, kurtosis,
missing data, and even outliners see Green &Salkind, 2014).
Sample Size
In this study, I used a sample size calculator to determine the appropriate sample
size for the population. The sample size was determined by setting the confidence level at
95%, a confidence interval of five, and using a population size of 100,000. The resulting
sample size recommended for the study was 383 medical records. The numbers of males
to females within the study from the sample was determined upon reviewing the data.
The total sample size after cleaning the data was 770 cases.
Justification for the Effect Size, Alpha Level, and Power Level Chosen
To improve the validity of the study, I selected an effect size. An alpha level of
0.5 was used to reduce Type 1 error and a power level of 80% was used to reduce Type 2
error. The choice of these figures was made for better external validity and improved
outcomes concerning generalization of the study findings.
Instrumentation and Operationalization of Constructs
In this study, I used the medical records of treatment, diagnosis, and
demographical information from the hospital as a secondary data set. In the following
subsections, the operationalization, target population, and data technique used for this
study are discussed.
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Operationalization
MVD association was the dependent variable in this study. The key independent
variables in this study were the individual and socioeconomic factors of the participants
in the hospital medical records from the years of 2013 to 2017. These included age,
gender, BMI, alcohol use, smoking, and A1C. I dichotomized the variables for logistic
regression analysis (e.g., persons age was reclassified into categories of less than 35
years old and above 35 years old, and marital status was classified into married and
single, with single being further broken down to include divorced, widowed, or
separated).
Target Population
In this study, the target population was persons who were diagnosed as having
CKD and diabetes during 2017. Any persons in the medical records that were over the
age of 16 years old and met the preceding criteria were considered for the study because
the legal definition of an adult in Grenada is those aged16 or older. Any person that did
not fit these basic criteria was not included in the study, including children under the age
of 16 years old.
Data Collection Technique
The data set was collected over a period of 12 months by hospital staff, especially
the nephrologists from 2013 to 2017. However, the field work was estimated to occur
from April 2018 – May 2018.I gathered the data for this study through the reviewing of
individual patient files during the determined research period and input the data into
Microsoft Excel.
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Research Questions and Hypotheses
RQ1: Is there an association between MVD and CKD severity among diabetes
patients with or without hypertension, when controlling for age, AIC, BMI,
gender, alcohol use, and smoking?
H01: There is no statistically significant association between MVD and
CKD severity among diabetes patients in Grenada with or without
hypertension when controlling for age, AIC, BMI, gender, alcohol use,
and cigarette smoking.
HA1: There is a statistically significant association between MVD and
CKD severity among diabetes patients in Grenada with or without
hypertension when controlling for age, A1C, BMI, gender, alcohol use,
and cigarette smoking.
RQ2: What is the significance between the prevalence of MVD and CKD severity
among patients in Grenada with diabetes with or without hypertension when
controlling for age, A1C, BMI, gender, alcohol use, and smoking?
H02: There is no significance between prevalence of MVD and CKD
severity among patients in Grenada with diabetes with or without
hypertension when controlling for age, A1C, BMI, gender, alcohol use,
and smoking.
HA2: The prevalence of MVD is ≥ 50%of CKD patients in Grenada with
diabetes with or without hypertension when controlling for age, BMI,
A1C, gender, alcohol use, and smoking.
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Data Analysis Plan
The analysis was in line with Figure 3.

• Simple Descriptive
Analysis (Frequencies,
Tables, Graphs,
Percentages and
Proportions

Step 1

Step 2
• Inferential Analysis
(Including:
Association
Coefficient, Logistic
regression, etc.)

• Inferences,
Decisions,
Conclusions and
Reports

Step 3

Figure 3. Data analysis process.
SPSS version25was used to analyze the data (IBM Corp, 2012). The data set was
validated using built in validation functions in SPSS. Then a simple descriptive analysis
was conducted. Identified variables were categorized and manipulated in accordance to
the research questions for effective data analysis. Charts, tables and graphs will be
created for visual description of the dataset. The first research question of if there is an
association between MVD and CKD severity among diabetes patients with or without
hypertension, when controlling for age, height, AIC, BMI, gender, smoking, and weight,
the statistical tests used to test this hypothesis will be the chi-square test and the binomial
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logistic regression due to the dependent variable being nominal and having more than
two categories.
The second research question, what is the significance between the prevalence of
MVD and CKD among patients with diabetes with or without hypertension when
controlling for age, A1C, BMI, gender, alcohol, and smoking in Grenada, according to an
organizational variables arising from the foundation of the SEM was statistically
evaluated by using the binomial logistic regression due to the dependent variable being
nominal and having more than two categories.
Threats to Validity
Since it is unclear if the medical records have been validated in the past, there is a
potential of several threats to the studies validity. Being a secondary data analysis, there
may have limitations to construct validity, limited number of variables available for
analysis with absence of some essential variables, inherent bias, missing data and
unaccounted errors in data collection. In addition, as this data were collected from 2013
to 2017, there could be significant changes to data storage and access to data archived
medical data in Grenada. To minimize these threats, the data were validated using the
SPSS preloaded rules.
Limited work hours, lack of clearance to enter some data on a regular basis, and
lack of access to power outlet in available data area may affect coverage and limited
internal validity of the project. Also, there may have inconsistent documentation of
patients as having MVD. This may result in a non random missing data scenario.
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Ethical Procedures
This study involved indirect research with human subjects as it entailed analysis
of secondary data looking at key variables collected in the 2013 to 2017 medical records.
The proposal has been approved by the primary data collector and data were collected
(The DHS Program, n.d.), because ethical approvals have been approved by the Walden
University IRB prior to proceeding to data retrieval, analysis and report development.
Relevant additional approvals for the form the data holders – Grenada Ministry of Health
Research Committee was obtained. These approvals enabled me to enter the data, analyze
and develop result report. The approvals gave me the permission to publish the findings
of the study in peer reviewed journals. As the dataset still belonged to the Government of
Grenada, all saved data sets were deleted from my portable hard drive after analysis and
report development. The product of this secondary data analysis was shared with the
Grenada Ministry of Health – if they request for it. Individual identifying information
was removed, and data anonymized to protect the participants before the analysis.
Dataset Treatment Post Analysis
Data set was deleted from the system upon completion of analysis and study.
Summary
In Section 2 of this inquiry, I elaborated on the research design (cross-sectional
quantitative approach of inquiry), rationale and methodology of the study. In describing
the methodology, the study population (Grenada), study area using the 2013 - 2017
medical records from the hospital, national population census, secondary data set
management technique, sampling and sampling procedure, and instrumentation and
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operationalization of constructs were described. In describing the instrumentation and
operationalization of constructs, the section operationalized the variables by explaining
the dependent and independent variables and their means of measurement, data collection
and management techniques and data analysis plan. In addition, the section also discussed
threats to validity and ethical considerations and procedures. In Section 3, we
investigated analyzing the results, and interpreting its finds as it relates to the research
questions.
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Section 3: Presentation of Results and Findings
Introduction
The purpose for this quantitative, cross-sectional study was to determine if there
is an association between MVD and CKD severity in persons with diabetes in Grenada
among persons who visited the hospital between 2013 and 2017as well as to evaluate the
prevalence of MVD. The research questions and hypotheses that guided this study were:
RQ1: Is there an association between MVD and CKD severity among diabetes
patients with or without hypertension, when controlling for age, AIC, BMI,
gender, alcohol use, and smoking?
H01: There is no statistically significant association between MVD and
CKD severity among diabetes patients in Grenada with or without
hypertension when controlling for age, AIC, BMI, gender, alcohol use,
and smoking.
HA1: There is a statistically significant association between MVD and
CKD severity among diabetes patients in Grenada with or without
hypertension when controlling for ageA1C, BMI, gender, alcohol use, and
smoking.
RQ2: What is the significance between the prevalence of MVD and CKD severity
among patients in Grenada with diabetes with or without hypertension when
controlling for age, A1C, BMI, gender, alcohol use, and cigarette smoking?
H02: There is no significance between prevalence of MVD and CKD
severity among patients in Grenada with diabetes with or without
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hypertension when controlling for age, A1C, BMI, gender, alcohol use,
and cigarette smoking.
HA2: The prevalence of MVD is ≥ 50%and CKD patients in Grenada with
diabetes with or without hypertension when controlling for age, BMI,
A1C, gender, alcohol use, and cigarette smoking.
In this section, I present the data collection, the results, and a summary. I analyzed
the hospital medical records of patients with diabetes and CKD for the for mentioned
year range using SPSS Version 25. The data were validated using SPSS validation
functions. Descriptive analyses of both the recoded, when necessary, and coded variables
were conducted to align with the research questions. Data were then cleaned to spot and
rectify data errors, mitigating its potential negative impact on study results. Next, I
reviewed the analyzed data to ensure validity and conducted further analytical tests using
SPSS.
Data Collection of Secondary Data Set
For this study, I used the medical records from a hospital in Grenada, West Indies.
Patient medical files were obtained through the medical records department of the
hospital, and medical records department staff was guided by the proposal for data
collection from 2013 to 2017. The General Hospital is the main hospital for the tri-islands
of Grenada, Carriacou, and Petite Martinique. Patient files used for analysis were
gathered by the medical records department of the hospital based on the research criteria
of the person’s initial hospital interactions (i.e., diabetes, CKD, and hypertension),which
was approved by IRB committee, and were presented to me as they were available. Due
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to limited staffing, files only became available when the staffing was available to gather
the data between their other duties to the hospital. Patient files contained a minimum
primary diagnosis of diabetes, and many contained not only secondary diagnoses but also
various procedural codes.
The use of medical records is essential to the determination of the effectiveness of
not only the healthcare system but also for the evaluation of patient care. Though there
are other medical facilities on the islands, all major medical procedures and specialists
are located at the hospital. The 2013 to 2017 medical records contain data that represents
the population of Grenada, Carriacou, and Petite Martinique. It is through evaluation of
these records that I determined if the study null hypotheses could be accepted or rejected.
Limitations
There were a few discrepancies related to the secondary data collection for
analysis. I originally proposed to use only data from 2016; however, due to the small
sample size, this was updated to use all patient files from 2013 to 2017, thus making the
study a retrospective analysis. The change in data set study range resulted in a longer
time for data collection timeframe than intended. Additionally, many basic fields were
missing in the intake portion of the patient’s files. For example, height, weight and BP
were either incorrectly noted (e.g., obese for weight, A1C, or instead of a number the
words HI for BP) or not noted at all. This caused difficulty in determining BMI for many
for the patient files, and therefore, the data were not controlled for this variable along
with weight, A1C, height, and BMI.
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The data screened for patients aged 16–100 years old with a diagnosis of diabetes
resulted in 998 records. However, due to many files missing data for the specific study
period or having no laboratory report or medical notation of laboratory procedures done,
the final sample included 770medical records. Female participants made up the largest
demographic group (57.9%). Most participants (58.8%) were between, equal, to or over
the age of 60 years old, with many participants (76.7%) being diagnosed with having
hypertension and 35.6% of persons found to have Stage 2 CKD. Table 1 shows the
frequency of participants by population characteristics. Additionally, most of the
participants were reported as not smoking (92.1%) or drinking (77%), with many
participants reporting their frequency of drinking or smoking as never (78.3%, 89.7%,
respectively). As it relates to CKD severity and being categorized as either less severe
(i.e., CKD Stage 1 or 2) or severe (i.e., CKD Stage 3A, 3B, 4, or 5) determined by eGFR,
most cases was defined as less severe CKD (57.6%). See Tables 1 and 2.
Table 1
Frequency Distribution for Study Population Characteristics
Variables
Gender

Age group

Categories

N

Valid%

Male

324

42.1

Female

449

57.9

16–19

4

0.5

20–24

4

0.5

25–29

10

1.3

30–34

5

0.6

35–39

22

2.9

48

Diagnosed with
hypertension

CKD stage

40–44

34

4.4

45–49

58

7.5

50–54

74

9.6

55–59

106

13.8

≥60

453

58.8

Yes

584

76.7

No

177

23.3

Stage 1

167

21.9

Stage 2

271

35.6

Stage 3A

113

14.8

Stage 3B

92

12.1

Stage 4

67

8.8

Stage 5

51

6.7

Categories

N

Valid %

Yes

174

23

No

581

77

Daily

2

0.3

Socially

14

2.1

Occasionally

79

11.7

Former

52

7.7

Never

529

78.3

Yes

60

7.9

Table 2
Frequency Distribution for Research Sample
Variables
Alcohol

Frequency of alcohol
use

Smoke

49

Frequency of smoking

CKD severity

No

695

92.1

Daily

1

0.1

Occasionally

4

0.6

Former

67

9.6

Never

629

89.7

Less severe

438

57.6

Severe

323

42.4

Results
In order to answerRQ1, I first conducted descriptive statistics for the variables of
(a) age, (b) A1C, (c) BMI, (d) gender, (e) smoking, (f) hypertension, and (g) CKD
severity. Age, BMI, and A1C were continuous variables; however, due to many variable
points missing for height, weight, BMI, and A1C, they were not included in the
analysis(see Table 3). The ordinal variables of gender, smoking, alcohol use,
hypertension, and CKD severity, are represented in Table 3. A chi-square test was
conducted to determine association to address RQ1 of this study. This test was used as
the primary statistical analysis for evaluating whether there was an association between
CKD and its various potential contributing health behavior factors. Finally, a binomial
logistic regression was conducted to determine if MVD was predicted by the independent
variables of age group, gender, smoking, cholesterol, ACR severity, hypertension, and
MVD and the dependent variable of CKD.
Table 3
Variables Removed from the Analysis
Category

# of Possible Cases

# of Missing Data
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BMI

770

732

Height

770

706

Weight

770

676

A1C

770

545

Table 4
Binary Logistic Regression Analysis Predicting Likelihood of Chronic Kidney Disease Severity
Association without Drinking with p value, OR, and 95% CI
Variables

B

p value

OPR

95%CI

Gender (ref =
female)

0.207

0.480

1.230

Lower
0.692

Upper
2.184

Age

0.304

0.009

1.355

1.080

1.702

Smoke

-0.868

0.104

0.420

0.147

1.196

-0.009

0.976

0.991

0.535

1.836

0.223

0.632

1.250

0.502

3.114

-0.571

0.130

0.565

0.270

1.182

MVD

0.019

0.968

1.020

0.398

2.614

Constant

-3.279

0.026

(ref = no)
Cholesterol
(ref = high)
ACR severity
Hypertension
(ref = yes)

Using the sample size of N= 761, I conducted a chi-square test for association to
evaluate whether a person’s gender is associated with CKD. The two variables were the
gender of the participants with two levels (i.e., male and female) and the diagnosis of
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CKD with two levels (i.e., less severe and severe). The results in Table 5showed no
statistically significant association between a person’s gender and CKD diagnosis, X2 (1)
= 0.607, p = 0.436, Cramer’s V = 0.028. Therefore, I failed to reject the null hypothesis
that there was no association between the gender and CKD. Cramer’s V correlation also
provides the strength of the relationship. A value of 0 indicates no association or
difference, and a value of 1.0 indicates a very strong or perfect association. Cramer’s V
correlation showed a very weak or no association between the variables.
Table 5
Chi-Square Results for Gender and Chronic Kidney Disease Severity
Variables

Value

df

p value

Person chi-

0.607

1

0.436

0.608

1

0.436

square (X2 )
Likelihood
ratio
Cramer’s V

0.028

N of valid

761

0.436

cases

The cross-tabulation chi-square test of gender as it relates to CKD severity in
Table 6shows that 43.4% (190 out of 438) of male participants was found to have a less
severe case diagnosis of CKD severity and 40.6% (131 out of 323) was found to have a
severe case diagnosis of CKD severity, while 56.6% (248 out of 438) of female
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participants was found to have less severe case diagnosis of CKD severity and 59.4%
(192 out of 323) had a severe case diagnosis of CKD severity. The results from the chisquare tests for association, as shown in Table 5 & 6,failed to reject the null hypothesis
that there was no statistically significant association between the patients’ gender and
CKD severity.

53
Table 6
Chi-Square Results Crosstabulation for the Development of Chronic Kidney Disease Severity and
Gender
Gender

CKD

Less severe

Total

Male

Female

Count

190

248

438

Expected

184.8

253.2

438.0

% within CKD

43.4%

56.6%

100.0%

Count

131

192

323

Expected

136.2

186.8

323.0

% within CKD

40.6%

59.4%

100.0%

Count

321

440

761

Expected

321.0

440.0

761.0

42.2%

57.8%

100.0%

Count

Severe

Count

Total

Count
% within CKD

Utilizing the sample size valid cases N= 753, a Chi-square test for association was
conducted to assess the association between hypertension and CKD severity. The two
variables were hypertension with two levels (Yes and No) and the contraction of CKD
with two levels (less severe and severe). Table 8(chi-square cross-tabulation table) shows
that 82.2% of the participants diagnosed with hypertension was shown to have severe
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CKD levels, while 17.8% of the patients without hypertension tested was found to have
had severe CKD levels. Seventy-three percent of patients that did have hypertension had
less severe CKD, while 27% without hypertension had less severe CKD. The result in
Table 7 reveals a statistically significant association between the presence of
hypertension and CKD severity, X2(1) = 9.61, p<0.05, Cramer’s V = 0.11. As a result, the
null hypothesis should be rejected that there was no statistically significant association
between hypertension and CKD severity. The observed difference is statistically
significant, and therefore is proof to reject the null hypothesis. Cramer’s V correlation in
Table 7also provides the strength of the relationship. Cramer’s V correlation shows a
small effect between the variables. The result as shown in Table 7validates the alternative
hypothesis that there was an association between hypertension and CKD severity.
Table 7
Chi-Square Results for Hypertension and Chronic Kidney Disease Severity
Variables

Value

df

p value

Person chi-

9.608a

1

0.002

9.809

1

0.002

square (X2 )
Likelihood
ratio
Cramer’s V

0.113

N of valid

753

cases

0.002
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Table 8
Chi-Square Results Crosstabulation for the Development of Chronic Kidney Disease Severity and
Hypertension
Hypertension

CKD

Less severe

Severe

Total

Count
Expected
Count
% within CKD
Count
Expected
Count
% within CKD
Count
Expected
Count
% within CKD

No
314
331.8

Yes
119
101.2

Total
433
433.0

72.5%
263
245.2

27.5%
57
74.8

100.0%
320
320.0

82.2%
577
577.0

17.8%
176
176.0

100.0%
753
753.0

76.6%

23.4%

100.0%

Using the sample size of N= 723, a chi-square test for association was conducted
to evaluate whether ACR severity is associated with CKD. The three variables were the
ACR of the participants with three levels (normal to mildly increase, moderately severe,
and severely increased) and the diagnosis of CKD with two levels (less severe and
severe). The result in Table 8 shows no statistically significant association between ACR
severity and CKD diagnosis, X2(2) = 2.194, p = .334, Cramer’s V = 0.055. Therefore, the
null hypothesis could not be rejected that there was no association between the ACR
severity and CKD. Cramer’s V correlation shows a very weak or no association between
the variables.
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Table 9
Chi-Square Results for ACR Severity and Chronic Kidney Disease Severity
Variables

Values

Df

Person chi-square (X2)

2.194

2

Likelihood ratio

2.166

1

Cramer’s V

0.055

Number of valid cases

p value
0.334
0.339
0.334

723

The cross-tabulation chi-square of gender as it relates to CKD severity in Table
10 show that 3.1% (13 out of 420) of persons with normal to mildly increased ACR
levels was found to have less severe case diagnosis of CKD; 92.9% (390 out of 420) of
persons with moderately severe ACR levels was found to have less severe case diagnosis
of CKD; and 4.0% (17 out of 420) of persons with severe ACR levels was found to have
less severe case diagnosis of CKD. In comparison, the same table showed that 4.6% (14
out of 303) of persons with normal to mildly increased ACR levels was found to have
severe case diagnosis of CKD; 89.8% (272 out of 303) of persons with moderately severe
ACR levels was found to have severe case diagnosis of CKD; and 5.6% (17 out of 303)
of persons with severe ACR levels was found to have severe case diagnosis of CKD. The
results from the chi-square test for association as shown in Table 8 and9 sustain the null
hypothesis that is no statistically significant association between ACR severity and CKD
severity. Therefore, the null hypothesis cannot be rejected.
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Table 10
Chi-Square Results Crosstabulation for Chronic Kidney Disease Severity and ACR Severity
ACR Severity
Normal to

Moderately

Severely

Mildly

Increased

Increased

Total

Increased
CKD

Less severe

Count

13

390

17

420

Expected

15.7

384.6

19.8

420.0

3.1%

92.9%

4.0%

100.0%

Count

14

272

17

303

Expected

11.3

277.4

14.2

303.0

4.6%

89.8%

5.6%

100.0%

Count

27

662

34

723

Expected

27.0

662.0

34.0

723.0

3.7%

91.6%

4.7%

100.0%

Count
% within
CKD
Severe

Count
% within
CKD
Total

Count
% within
CKD
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With the sample size valid cases N= 255, a Chi-square test for association was
conducted to assess the association between cholesterol and CKD severity. The two
variables were cholesterol with two levels (normal and high) and the contraction of CKD
with two levels (less severe and severe). Table 12(chi-square cross-tabulation table)
shows that 72.7% of the participants with normal cholesterol levels were shown to have
severe CKD levels, while 27.3% of the patients with high cholesterol tested were found
to have severe CKD levels. Seventy-two percent of patients that had normal cholesterol
had less severe CKD, while 28% with high cholesterol had less severe CKD. The result
in Table 11 revealed no statistically significant association between the cholesterol and
CKD severity, X2(1) = 0.034, p = 0.847, Cramer’s V = 0.012. As a result, the null
hypothesis should be accepted that there is no statistically significant association between
cholesterol and CKD severity. The observed difference is not statistically significant, and
therefore was proof to accept the null hypothesis. Cramer’s V correlation in Table 10 also
provides the strength of the relationship. Cramer’s V correlation shows a small to no
effect between the variables. The result as shown in Table 11validates the null hypothesis
that there was no association between cholesterol and CKD severity.
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Table 11
Chi-Square Results for Cholesterol and Chronic Kidney Disease Severity
Variables

Value

df

p value

Person’s chi-square (X2)

0.037

1

0.847

Likelihood ratio

0.003

1

0.847

Cramer’s ratio

0.012

Number of valid cases

0.847

255

Table 12
Chi-Square Crosstabulation for Chronic Kidney Disease Severity and Cholesterol

CKD

Less severe

Severe

Total

Count
Expected
Count
% within CKD
Count
Expected
Count
% within CKD
Count
Expected
Count
% within CKD

Cholesterol
Normal
High
96
38
96.7
37.3

Total
134
134.0

71.6%
88
87.3

28.4%
33
33.7

100.0%
121
121.0

72.7%
184
184.0

27.3%
71
71.0

100.0%
255
255.0

72.2%

27.8%

100.0%

Observing the sample size of valid cases N= 761, a Chi-square test for association
was conducted to assess the association between MVD and CKD. The two variables were
MVD with two levels (yes and no) and the development of CKD with two levels (less
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severe and severe). Table 14(chi-square cross-tabulation table) shows that 12.4% of the
participants diagnosed with MVD was shown to have severe CKD levels, while 87.6% of
the patients without MVD tested was found to have severe CKD levels. Fifteen percent of
patients that did have MVD had less severe CKD, while 85% without MVD had less
severe CKD. The result in Table 12 revealed no statistically significance association
between the presence of MVD and CKD severity, X2(1) = 0.782,p = 0.376, Cramer’s V =
0.032. As a result, the null hypothesis should be accepted that there was no statistically
significant association between MVD and CKD severity. The observed difference is not
statistically significant, and therefore is proof to accept the null hypothesis. Cramer’s V
correlation in Table 13also provides the strength of the relationship. Cramer’s V
correlation shows a small effect between the variables. The result as shown in Table 12
validates the null hypothesis that there was no association between MVD and CKD
severity.
Table 13
Chi-Square Results Microvascular Disease and Chronic Kidney Disease Severity
Variables

Value

df

p value

Person chi-square (X2 )

0.782a

1

0.376

Likelihood ratio

0.788

1

0.375

Cramer’s V

0.032

N of valid cases

761

0.376
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Table 14
Chi-Square Cross-Tabulation for Chronic Kidney Disease Severity and Microvascular Disease
MVD _Recode

CKD

Less severe

Yes

No

Total

64

374

438

59.9

378.1

438.0

14.6%

85.4%

100.0%

40

283

323

44.1

278.9

323.0

12.4%

87.6%

100.0%

104

657

761

Expected
Count

104.0

657.0

761.0

% within CKD

13.7%

86.3%

100.0%

Count
Expected
Count
% within CKD

Severe

Count
Expected
Count
% within CKD

Total

Count

The result from the logistic regression analysis in Table 15shows that age group
and drinking does significantly predict the odds of CKD severity among the participants
while controlling for gender, and smoking(OR = 1.320, 95% CI [1.191-1.463], p< 0.05;
OR = 1.801, 95% CI [1.212-2.676], p<0.05, respectively). The result showed that the
difference in age and drinking was associated with the development of CKD. As a result,
I accepted the alternative hypothesis of statistically significant difference in the odds of
developing CKD between age groups, as well as drinking or non-drinking, and reject the
null hypothesis of no significant odds of CKD contraction between age groups, plus
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drinking or non-drinking, after adjusting for gender, and smoking. In contrast, Table
15shows that gender and smoking status did not significantly predict the odds of
developing CKD among the participants while controlling for age group, and drinking
(OR = 1.012, 95% CI [0.737-1.390],p = 0.939; OR = 1.759, 95% CI [0.923-3.353], p
=0.086, respectively). Therefore, the result shows that the differences in gender and
smoking or non smoking were not associated with the development of CKD. As a result,
I rejected the alternative hypothesis of statistically significant difference in the odds of
developing CKD between male and female and smoking and non smoking, and accept the
null hypothesis of no significant odds of CKD contraction between male and female and
smoking and non smoking after adjusting for age, and drinking.
Table 15
Binary Logistics Regression Analysis Predicting Likelihood of Chronic Kidney Disease Severity
Association with p value, OR, and 95% CI
Variables

Gender (ref = male)

B

0.012

p value

OR

0.939

1.012

95% CI
Lower

Upper

0.737

1.390

Age

0.278

0.000

1.320

1.191

1.463

Smoke
(ref = no)

0.565

0.086

1.759

0.923

3.353

Drink status
(ref =no)

0.589

0.004

1.801

1.212

2.676

Constant

-3.802

0.000
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The result from the logistic regression analysis in Table 16 shows that cholesterol,
ACR severity and MVD does not significantly predict the odds of developing CKD
among the participants while controlling for age, gender, smoking, and drinking (OR =
0.904, 95% CI [0.509-1.606], p = 0.73; OR = 1.296, 95% CI [0.532-3.157], p = 0.57; OR
= 1.043, 95% CI [0.417-2.607], p = 0.93 respectively). The result shows that the
difference in cholesterol, ACR severity and MVD are not associated with the
development of CKD. As a result, I rejected the alternative hypothesis of statistically
significant difference in the odds of developing CKD between person with normal and
high cholesterol, normal to severely increase ACR levels, MVD or no MVD diagnosis,
and accepted the null hypothesis of no significant odds of CKD contraction between
person with normal and high cholesterol, normal to severely increase ACR levels, MVD
or no MVD diagnosis. However, Table 16 showed that hypertension did significantly
predict the odds of developing CKD among the participants while controlling for age,
gender, smoking, and drinking (OR = 2.635, 95% CI [1.328-5.226], p< 0.05). Therefore,
the result shows that the differences in hypertension and no hypertension were associated
with the development of CKD. Thus, I accepted the alternative hypothesis of statistically
significant difference in the odds of developing CKD among persons with and without
hypertension and reject the null hypothesis of no significant odds of CKD among persons
with and without hypertension after adjusting for age, gender, smoking, and drinking.
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Table 16
Summary of Binary Logistic Regression Analysis and Socioecological Model
Variables

B

p value

OR

95% CI
Lower

Upper

Cholesterol

-0.101

0.730

0.904

0.509

1.606

ACR severity

0.259

0.569

1.296

0.532

3.157

Hypertension

0.969

0.006

2.635

1.328

5.226

0.042

0.929

1.043

0.417

2.607

-1.281

0.209

(ref = no)
MVD
(ref = no)
Constant

A Pearson correlation coefficient was calculated to assess the relationship
between CKD severity and variables that could influence the severity of CKD, i.e.
hypertension, drinking, frequency of drinking, smoking, frequency of smoking, gender,
cholesterol, MVD and/or sickling. There was a positive correlation found between four
variables: hypertension (r=-1.113, N= 753,p= .002), drinking (r = .139, N= 747, p<.001),
drink frequency (r = .130, N= 671, p = .001), and smoke (r= .097,n = 747, p = .008).
Table 17summarizes the results. Overall, there was a strong, positive correlation between
CKD severity, hypertension history, drinking, drink frequencies and cigarette smoking.
Table 17
Correlation
Variables

Hypertension

Drink

Drink

Smoke
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Frequency
CKD

Pearson

-1.113**

0.139**

0.130**

0.097**

0.002

0.000

0.001

0.008

753

747

671

747

-1.113**

0.139**

0.130**

0.097**

Correlation
Sig. (2-tailed)
Number of cases
Pearson
Correlation
**. Correction is significant at the p<0.01 level (2-tailed).

Summary
I presented the results for the 2013 to 2017 Grenada medical records, to evaluate
the relationship between MVD and CKD severity among diabetes patients with or
without hypertension when controlling for age, AIC, BMI, gender, alcohol, and smoking
in Grenada. A total of 998 files were reviewed, of which 770 cases were examined. I
conducted a binary logistic regression to determine the association between CKD
severity, the presence of hypertension, age, gender, alcohol, smoking, ACR severity and
MVD. Drinking, age group, and history of hypertension were all significant predicators
of CKD severity. Based on the statistical significance I accepted the null hypothesis that
there was no association between MVD and CKD severity among diabetes patients with
or without hypertension when controlled for AIC, BMI, gender, alcohol, ACR severity,
and smoking in Grenada. A chi-square test was used to assess whether there was an
association between CKD severity and the variables gender, age group, smoke, smoke
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frequency, drinking, ACR severity, cholesterol, and MVD. An association was found
between, age group and hypertension; therefore, I rejected the null hypothesis. In Section
4, I discuss the findings of my research, the potential application to the practice of the
public health profession, and implications for positive social change.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose for this quantitative, cross-sectional study was to determine if there
is an association between MVD and CKD severity in persons with diabetes in Grenada
who visited the Grenada General hospital with diabetes between 2013 and 2017as well as
the prevalence of MVD. I also ascertained whether there is significance between the
prevalence of MVD and CKD among patients with diabetes with or without hypertension
when controlling for age, BMI, A1C, gender, alcohol use, and smoking status in Grenada.
The key findings from the study were that smoking, drink frequency, and history of
hypertension were significant predictors of CKD severity.
In Section 4, I provide an interpretation of the findings as they relate to existing
literature and the SEM. The section also includes the limitations of the study and
recommendations for future research. Finally, I discuss the implications of the study for
professional practice and positive social change.
Interpretation of the Findings
Age Group and Chronic Kidney Disease Severity
For RQ1, I found an association between age group, hypertension, smoking,
drinking, drink frequency, and CKD severity among persons in Grenada with diabetes. In
this study, persons over the age of 60 years old and smoking frequency were associated
with have a very large effect on CKD severity. These findings add to the literature
documenting age being a contributing factor in increased risk for diseases. While age has
been shown to impact health outcomes previously, the results from the current study may
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be novel with a focus on health outcomes within the Caribbean and from a
socioecological standpoint. A higher tendency for persons over the age of 60 years old to
be at risk for CKD compared to younger persons suggests age adversely impacts health
outcomes more than gender as it relates to CKD severity.
Drinking and Chronic Kidney Disease Severity
In this study, I found that drink frequency was associated with CKD severity.
Persons who reported as never having had alcohol comprised of 78% of the study
population, and I found a statistically significant relationship between drink frequency
and CKD severity among this group. CKD severity was used as the constant for the
regression analysis, with less severe patients comprising of 58% of the study population.
The results showed that as drink frequency increased from never drinking to daily (β
=.06, p = < .005, OR =1.801), the severity of CKD on the person increased by.06. The
results of the current study, when compared to existing literature, also indicated that there
is a significant association between frequency of drinking and CKD severity. In this
study, females who drank more frequently were more likely to have increased CKD
severity. This study may be the first to include drink frequency among female
participants or a predominantly Black study population, whereas previous studies
excluded drink frequency among females as it relates to CKD severity (Funakoshi et al.,
2012; Sato et al., 2014).
Microvascular Disease and Complications of Chronic Kidney Disease
Analysis for RQ2 indicates that although age group, smoke frequency, drink
frequency, ACR severity, sickling, and MVD had a significant relationship with CKD
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severity, they differed in the effect they had on CKD severity. The severity of a person’s
CKD may be associated with number of risk factor contributors and underlining health
conditions (i.e. sickling and/or amputations). The results for RQ2 indicated a statistically
significant relationship between MVD, hypertension, age group, and CKD severity,
which predicts an increased odd of having more severe CKD outcomes for older women
(i.e., mean age of 64 years old). For MVD, there was a statistically significant difference
of .94 with a Cohen’s d effect size of 1.04. History of hypertension was also statistically
significant, with a mean square of1.7 and Cohen’s d effect size of .42 compared to.30 for
those having documented cholesterol issues. A person’s age group was also statistically
significant of p = 0.00 and a Cohen’s d effect size of 5.82, with participants 60 years old
or older having a higher risk of more severe levels of CKD. Although vascular
complications, prevalence, progression, and pathophysiology differ in men and women,
the presence of diabetes among women poses a higher risk of vascular complications
(Maric-Bilkan, 2017). Kiberd and Clase (2002) observed that among gender-race groups,
during the lifetime of ESRD for a 20-year-old, Black women were 7.8 times more likely
to die when compared to breast cancer among Black women.
The results of this study were like those of Maric-Bilkan (2017) in that a
statistically significant association was found in which women has an increased risk of
MVD complications compared to men and, therefore, more severe forms of CKD.
Additionally, this study finding showed the average age for women having more severe
forms of CKD was 64 years old. The findings from the present study expound on the
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existing literature regarding that age, in addition to gender, can be a predictor of CKD
severity.
The Social Ecological Model and Association Between Chronic Kidney Disease
The theoretical framework that guided this study was SEM. This theological
construct addresses the association between CKD risk factors, such as hypertension and
diabetes, and addresses the complexity of socioenvironmental factors (Levey et al.,
2003). At the community level, when strategic social norm changes are facilitated with
regards to health behavior, prescribed interventions are more effective (Golden & Earp,
2012). The connection between delay in CKD progression and its proposed cost benefit
to the health care system is substantial when managed effectively (Ontario Renal
Network, 2016). The results of the study indicated that MVD, age group, and drink
frequency were associated with increased risk of development of more severe levels of
CKD.
Within the medical system of the public hospital, there are currently two doctors
to address the health needs of CKD patients. The study population demographics (N =
775), of which only (N=165)22% of persons are currently receiving treatment within the
Grenada, indicated that with only two specialized doctors in neuropathy available for
limited service days, there could be a deficiency in the provision of adequate care.
Decreased awareness of CKD and delayed referrals to nephrologists are associated with
unsatisfactory prognosis, such as increased mortality, longer hospitalizations, and rapid
advancement of CKD to ESRD (Smart et al., 2014). According to the theory of the SEM
and Schroeder (2007), a key determinant in enacting social environmental change is a
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strategic focus on the improvement of the social factors, health care, and the environment
in order to curb persistent health inequalities.
I used the SEM in this study to evaluate the risk factors associated with MVD and
CKD severity not only from an individual level but for organizational structures handling
CKD patients that affect how and how well services are provided to individuals within
the hospital (see UNICEF, 2014). The advantage of using the SEM was that theory could
be employed to evaluate MVD and CKD severity associations from a community level
and could accentuate the fact that a continued dialogue is needed to address the
organizational, social, and environmental factors contributing to CKD disparities and
further cost-effective policy interventions are needed to shorten the disparity gap (see
Nicholas, Kalantar-Zadeh,& Norris, 2015).
Limitations of the Study
I obtained the data for this study from the 2013 to 2017 medical records of the
hospital. The study findings may be generalized to the tri-island state of Grenada,
Carriacou, and Petite Martinique because the sample was taken from the main hospital
that contained data from persons that are from all three islands from 2013 to 2017.The
findings could also be used for the development of further studies on chronic diseases in
the country.
The sample collected provided a good representation of the health of the
population because it included all cases for persons 16 years old and older. Though it
does provide a good demonstration of the population, the use of a national database has
its limitations. The classification of CKD stages was based on the National Kidney
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Foundation’s Kidney Disease Outcomes Quality Initiative. These diagnoses may be
incomplete due both an absence of a common definition of CKD and misclassification of
stage progression (Hogg et al., 2003). A notable limitation of this study was the lack of
consistent data collection for the some of the reported fields. Another significant
limitation of this study was the ease of accessibility to medical records. Data are only in
paper format that required the pulling of individual patient files in order to review them
for this study. Additionally, records did not all have the same basic data collected, (i.e.,
weight, height, blood sugar or BP); therefore, the possibility exists that there could be a
correlation between CKD stages and BMI.
Recommendations
The results of this study showed that additional research is needed to identify
interventions that can be used to improve overall outcomes of persons with MVD and/or
CKD with a focus on improving data collection from all necessary medical staff.
Although there have been improvements in the care of persons with kidney disease and
MVD, not all persons have access to such care. I recommend further study of the impact
of decreasing medical staffing has on the outcomes of persons with CKD and MVD as
well as the financial implications to the government in order to provide a more accurate
trajectory of these diseases on Grenada. Further studies also are needed to examine the
effectiveness of health education in the matters of CKD and MVD to the general
population.
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Implications for Professional Practice and Social Change
The implications of this study on public health practice include the development
of risk assessment of MVD for both men and women. The findings of this study could be
used by practitioners to provide age-appropriate and culturally sensitive health education
to their patients on the risks of developing MVD and/or CKD. Sue-Hsien et al (2011)
found that patients who actively participated in care through education not only improved
their relationship with the clinician but also embraced CKD treatment, maximizing
positive outcomes. Health educators, such as the health promotion team and nursing staff,
could develop literature for the public about the risk factors that contribute to CKD and
MVD. By having an evolving CKD education program focused on patient involvement,
symptom management, and disability potential while emphasizing CKD risk factor
monitoring, like hypertension and drinking habits, then both doctors and patients can
work together to minimize or eliminate the long-term effects of CKD not only on the
individuals but also on the community and health system. (see Corbin & Strauss, 1991).
The results of this study could also result in senior medical officers along with the chief
medical officer working to develop protocols for not only efficiently tracking CKD and
MVD cases but also conducting further studies on the long-term implications to the
community. Finally, the findings of this study could lead to the recruitment of additional
specialized medical staff to better assess, educate, and treat patients affected by these
diseases. The application of these proposed interventions could lead to long-term
reductions in CKD and MVD cases and improvement in patient outcomes.
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Along with implications to the public health practice in Grenada, this study also
has implications for positive social change. The observed correlations confirm the need
for increased efforts to improve community outcomes among drinkers, those with a
history of hypertension, and smokers to reduce the burden of CKD within society. The
findings of this study could provide evidence for health care professionals, public health
providers, and governmental officials to use to enhance national guidelines and change
health policy to not only improve but reduce CKD outcomes in all tri-island members.
The results of the study may also shed light on questions that help public health experts
understand not only why the type of social practices and their frequency puts them at a
higher risk of developing CKD-related complications, but also it provides the basis for
further study to expand the global impact for the health of Black persons around the
world.
Conclusion
In this study, I examined MVD and its relationship to CKD severity among
diabetes patients with or without hypertension, when controlling for age, AIC, BMI,
gender, and smoking. On average, older females were found to have more severe CKD
stages (i.e., Stages 3A– 5) as compared to men. Additionally, an assessment was made to
determine if there is a significant difference between MVD and complications of those
with or without diabetes among men at various age groups and women at various age
groups.
I found a statistically significant relationship with a large effect size between age
group, cigarette smoking status, cigarette smoking frequency, alcoholic drink frequency,
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ACR severity, sickling, and MVD. As age increased, there was increased risk for the
development of more severe levels of CKD among women. An increased level of CKD
severity in women 60 years old and older compared to men, suggests that factors
associated with gender negatively impact kidney health in women. The results of this
study will contribute to further studies on the impact that these risk factors have on CKD
patients’ long term as well as their impact on the community on a whole. Additionally,
the findings of this study lay the groundwork for investment into research on other
chronic diseases that directly or indirectly impact the lives of persons living within
Grenada.

76
References
Amann, K. & Ritz, E. (2000). Microvascular disease – the Cinderella of uraemic heart
disease. Nephrology Dialysis Transplantation, 15(10), 1493-1503.
doi:10.1093/ndt/15.10.1493.
American Diabetes Association. (2009). Diagnosis and classification of diabetes mellitus.
Diabetes Cares, 32(Supplement 1), 562-567. doi:10.2337/dc09-s062.
American Diabetes Association. (2013). Standards of medical care in diabetes -2013
Diabetes Care, 36(1), S11-S66. doi:10. 2337dc13-S011.
American Diabetes Association (2015a). Standards of medical care in diabetes. Diabetes
Care, 38(Suppl 1), S1-S93.
American Diabetes Association. (2015b). Statistics about diabetes- Overall numbers,
diabetes, and prediabetes. Retrieved from http://www.diabetes.org/diabetes
basics/statistics/?referrer=https://www.google.com/.
American Diabetes Association. (2016). Classification and diagnosis of diabetes.
Diabetes Cares, 39(Supplement 1), S13-S22. doi:10.2337/dc16-s005.
Amann, K., & Ritz, E. (2000). Microvascular disease – The cinderellas of uraemic heart
disease. Nephrology Dialysis Transplantation, 15(10), 11493-1503.
doi:10.1093/ndt/15.10.1493.
Anderson, G.F., Water, H., Pittman, P., Herbert, R., Chu, E., & Das, K. (2009). Noncommunicable chronic diseases in Latin America and the Caribbean.Baltimore,
MD: Bloomberg. School of Public Health, John Hopkins University.

77
Beckman, J. A., Duncan, M. S., Damrauer, S. M., Wells, Q. S, Barnett, J. V., Wasserman,
D. H.,…Freiberg, M. S. (2019). Microvascular disease, peripheral artery disease
and amputation. Circulation, 140(6), 449-468.
doi:10.1161/circulationaha.119.040672.
Bennett, N. R., Francis, D. K., Ferguson, T. S., Hennis, A. M., Wilks, R. J., Harris, E. N.,
&Sullivan, L. W.(2015). Disparities in diabetes mellitus among Caribbean
populations: Ascoping review. International Journal for Equity in Health, 14(1),
1-17. doi:10.1186/s12939-015-0149.
Brancati, F.L., Kao, W.H., Folsom, A.R., Watson, R.L.,&Szklo, M. (2000). Incident
Type 2diabetes mellitus in African American and White adults: The
Atherosclerosis Riskin Communities Study.Journal of the American Medical
Association, 283(17),2253-2259. Retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/10807384
Brown, K., Avis, M., & Hubbard, M. (2007). Health beliefs of African-Caribbean people
with Type 2 diabetes: Aqualitative study. British Journal of General Practice, 57,
461-469.
Brownrigg, J.R., Hughes, C.O., Burleigh, D., Karthikesalingam, A., Patterson, B.O.,
Holt, P.J.,… Hinchliffe, R.J. (2016). Microvascular disease and risk of
cardiovascular events among individuals with Type 2 diabetes: A population-level
cohort study. The Lancet Diabetes and Endocrinology, 4(71), 588-597.
doi:10.1016/S2213-8587(16)30057-2.

78
Caribbean Epidemiology Centre, PAHO/WHO Epidemiology Division. (2000). Leading
causes of death and mortality rates. Retrieved from
http://cadph.net/pdf/Mortality_Final_LR%20_%20061205.pdf.
Centers for Disease Control and Prevention (2011). National diabetes fact sheet: National
estimates and general information on diabetes and prediabetes in the United
States. Retrieved from
http://diabetes.niddk.nih.gov/DM/PUBS/statistis/DM_Statistics.pdf.
Centers for Disease Control and Prevention. (2012a). Diabetes report card 2012.Atlanta,
GA:U.S. Department of Health and Human Services. Retrieved from
http://www.cdc.gov/diabetes/pubs/pdf/DaibetesReportcard.pdf.
Centers of Disease Control and Prevention. (2012b). Age-adjusted prevalence of CKD
Stages 1-4 by Gender 1999-2012, Chronic Kidney Disease Surveillance.
Retrieved from https://nccd.cdc.gov/CKD/detail.aspx?Qnum=Q10
Centers for Disease Control and Prevention. (2014a). National diabetes statistical
report:Estimates of diabetes and its burden in the United States, 2014. Atlanta,
GA: U.S. Department of Health and Human Services.Retrieved
fromhttps://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetesreportweb.pdfhttps://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetesreportweb.pdf.
Centers for Disease Control and Prevention. (2014b). National diabetes statistics report.
Retrieved August 2014, from http://www.cdc.gov/diabetes/pubs/estimates14.htm

79
Center for Disease Control and Prevention. (2016). Making the diabetes and kidney
disease connection. Retrieved from
www.cdc.gov/diabetes/programs/initiatives/diabetes-kidneyconnection.htmlCenter for Disease Control and Prevention. (2019). Chronic
kidney disease in the United States. Retrieved from
https://www.cdc.gove/kidneydisease/publicationsresource/2019-nationalfacts.html
Center Intelligence Agency. (2017). The world factbook: Central America and
Caribbean, Grenada. Retrieved from https://www.cia.gov/library/publications/theworld-factbook/geos/gj.html.
Center Intelligence Agency. (2018). The world factbook: Grenada. Retrieved from
https://www.cia.gov/libary/publications/the-world-factbook/geos/gj.html.
Center Intelligence Agency. (2020). The world factbook: Grenada. Retrieved from
https://cia.gov/library/publications/the-world-factbook/geos/pring-gj.html.
Chapter 1: Definition and classification of CKD. (2013) Kidney International
Supplements, 3(1), 19-62. doi:10.1038/kisup.2012.64
Cheng, C. Y., Reich, D., Haiman, C. A., Tandon, A., Patterson, N., Elizabeth,
S.,...Altshuler, D. (2012). African ancestry and its correlation to Type 2 diabetes
in African Americans: T genetic admixture analysis in three US population
cohorts. PLoS One, 7(3), e32840. doi:10.1371/journal.pone.0032840.

80
Cheng, H.G. & Phillips, M.R. (2014). Secondary analysis of existing data opportunities
and implantation. Shanghai Archives of Psychiatry, 26(6), 371-375.
doi:10.119/j.iddn.1002-0829.214171.
Corbin, J.,& Strauss, A. (1991). Comeback: Overcoming disability. In A. Albrech (Ed.),
Readings on disability(pp. 137-158). Greenwich, CT: JAI Press.
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003). Prevalence of
chronic kidney disease and decreased kidney function in the adult US population:
Third National Health and Nutrition Examination Survey. American Journal of
Kidney Disease, 41(1),1-12.
Creswell, J. (2009). Research design: Qualitative, quantitative, and mixed methods
approaches (Laureate Education, Inc., custom ed.). Thousand Oaks, CA: Sage
Publications.Crews, D. C., Campbell, K. N., Liu, Y., Bussue, O., Dawkins, I., &
Young, B. A. (2017). Chronic kidney disease and risk factor prevalence in Saint
Kitts and Nevis: A cross-sectional study. BioMed Central Nephrology, 18(7).
doi:10.1186/s12882-016-0424-2.
Department of Health and Human Services. (2015). Diabetes- Long-term effects.
Retrieved from
https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/diabeteslong-term-effects.
Diabetes.co.uk. (2018). Diabetes and hyperglycemia. Retrieved from
https://www.diabetes.co.uk/Diabetes-and-Hyperglycaemia.html

81
Eknoyan, G., Lameire, N., Barsoum, R., Eckardt, K.U., Levin, A., Levin, N.,… Wang, H.
(2004). The burden of kidney disease: Improving global outcomes, Kidney
International, 66(4), 1310-1314. doi:10.1111/j.1523-1755.2004.00894. x.
Eldemire-Shearer, D., James, K., Morris, C., Holder-Nevins, D., Lawes, H., & Harris, M.
(2011). Chronic disease and ageing in the Caribbean: Opportunities knock at the
door. West Indian Medical Journal, 60(4),471-477.
Ezenwaka, C.E., Idris, S., Davis, G., & Roberts, L. (2016). Does obesity increase the
prevalence of chronic kidney disease in Caribbean Type-2 diabetes patients with
or without hypertension? International Journal of Diabetes Research, 5(1), 7-13.
doi:10.5923/j.diabetes.20160501.02.
Ezenwaka, C.E., Jones-LeCointe, A., Nwagbara, E., Seales, D., &Okali, F. (2008).
Anemia and kidney dysfunction in Caribbean Type 2 diabetic patients.
Cardiovascular Diabetology, 7(25),1-6. doi:10.1186/1475-2840-7-25.
Ferguson, T.S., Tulloch-Reid, M.K., Younger-Coleman, N.O., Wright-Pascoe, R.A.,
Boyne, M.S., Soyibo, A.K., & Wilks, R.J. (2015). Prevalence of chronic kidney
disease among patients attending a specialist diabetes clinic in Jamaica. The West
Indian Medical Journal, 64(3), 201–208. doi:10.7727/wimj.2014.084
Fonesca, V.A. (2006). Clinical diabetes: Translating research into practice.
Philadelphia, PA: Saunders, Elsevier. Retrieved from
https://www.amazon.com/Clinical-Diabetes-Vivian-Fonseca/dp/1416002731
Fonseca, V. A. (2009). Defining and characterizing the progression of Type 2
diabetes.Diabetes Care, 32(Suppl 2), S151-S156. doi:10.2337/dc09-S301.

82
Funakoshi, Y., Omori, H., Onoue, A.,Mihara, S., Ogata, Y., &Katoh, T. (2012).
Association between frequency of drinking alcohol and chronic kidney disease in
men. Environmental Health and Preventive Medicine, 17, 199-204.
doi:10.1007/s12199-011-0238-6.
Gattone, V. H. (2007). The kidney- Introduction to its structure and function. The FASEB
Journal, 21(5). doi:10.1096/fasebj.21.5.a2-d.
Golden, S.D., & Earp, J.A. (2012). Social ecological approaches to individuals and their
contexts: Twenty years of Health Education & Behavior health promotion
interventions. Health Education & Behavior,29, 364-372.
doi:10.1177/1090198111418634.
Graciolli, F.G., Neves, K.R., Barreto, F., Barreto, D.V., dos Reis, L.M., Canziani,
M.E.,…Moyses, R.M.A. (2017). The complexity of chronic kidney diseasemineral and bone disorder across stages of chronic kidney disease. Kidney
International,91(6), 1436-1446. doi:10.1016/j.kint.2016.12.029.
Groop, P., Thomas, M.C., Moran, J.L., Wadèn, J., Thorn, L.M., Mäkinen,
V.,…Forsblom, C. (2009). The presence and severity of chronic kidney disease
predict all-cause mortality in Type 1 diabetes. Diabetes, 58(7), 1651-1658.
doi:10.2337/db08-1543.
Gross, J. L., de Azevedo, M. J., Sliveiro, S. P., Canani, L. H., Caramori, M. L.,
&Zelmanovitz, T. (2005). Diabetic nephropathy: Diagnosis, prevention and
treatment. Diabetes Care, 28(1), 164-176. doi:10.2337/diacare.28.1.164

83
Health Grove. (2013a). Chronic kidney disease intheCaribbean – Statistics on overall
impact and specific effect on demographic groups. Retrieved from http://globaldiseaseburden.healthgrove.com/l/66934/Chronic-Kidney-Disease-in-Caribbean.
Health Grove. (2013b). Diabetes Mellitus in Grenada – Statistics on overall impact and
specific effect on demographic groups. Retrieved from http://global-diseaseburden.healthgrove.com/l/66327/Diabetes-Mellitus-in-Grenada
Hennis, A.J.M, Fraser, H.S., Johnnalagadda, R., Fuller, J., & Chaturvedi, N. (2004).
Explanations for the high risk of diabetes-related amputation in a Caribbean
population of Black African descent and potential for prevention. Diabetes Care,
27(11),2636-2641. doi:10.2337/diacare.27.11.2636.
Hennis, A., Wu, S.Y., Nemesure, B., Li, X., &Leske, M.C. (2002). Diabetes in a
Caribbean population: Epidemiological profile and implications. International
Journal of Epidemiology, 31(1), 234-239. doi:10.1093/ije/31.1.234.
Hicks, C. W., & Selvin, E. (2019). Epidemiology of peripheral neuropathy and lower
extremity disease in diabetes. Current diabetes reports, 19(10), 86.
doi:10.1007/s11892-019-1212-8.
Hogg, R. J., Furth, S., Lemley, K. V., Portman, R., Schwartz, G. J., Coresh, J., … Levey,
A. S. (2003). National Kidney Foundation’s Kidney Disease Outcomes Quality
Initiative clinical practice guidelines for chronic kidney disease in children and
adolescents: Evaluation, classification, and stratification. Pediatrics, 111(6),
1416–1421. doi:10.1542/peds.111.6.1416

84
Hospedales, C.J., Samuels, T.A., Cummings, R., Gollop, G., & Greene, E. (2011).
Raising the priority of chronic noncommunicable diseases in the Caribbean.Pan
American Journal of Public Health, 30(4),393-400. Retrieved from
https://scielosp.org/pdf/rpsp/2011.v30n4/393-400/en.
Index Mundi. (2018). Grenada demographic profile 2018. Retrieved from
https://www.indexmundi.com/grenada/demographics_profile.html
International Diabetes Federation (2015). IDFdiabetes atlas (7th ed.). Retrieved from
www.diabetesatlas.org.
Institute for Health Metrics and Evaluation. (2016). Grenada. Retrieved from
http://www.healthdata.org/grenada.
Jain, S. & Saraf, S. (2010). Type 2 diabetes mellitus – Its global prevalence and
therapeutic strategies. Diabetes and Metabolic Syndrome: Clinical Research and
Reviews, 4, 48-56. doi:10.1016/j.dsx.2008.04.011.
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B.,… Wang, A.Y.M.
(2013). Chronic kidney disease: Global dimension and perspectives. The Lancet,
382(9888), 260-272. doi:10.1016/S0140-6736(13)60687-X.
Kiberd, B.,&Clase, C. (2002). Cumulative risk for developing end-stage renal disease in
the US population. Journal of theAmerican Society ofNephrology,13(6), 16351644.
Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Workgroup.
(2013). KDIGO 2012 clinical practice guideline for the evaluation and
management of chronic kidney disease. Kidney Int Suppl., 3, 1-150.

85
Kim, C., Newton, K.M., &Knopp, R.H. (2002). Gestational diabetes and incidence of
Type 2 diabetes. Diabetes Care, 25(10), 1862-1868.
doi:10.2337/diacare.25.10.1862.
Krishnan, S., Cozier, Y.C., Rosenberg, L., &Palmer, J.R. (2010). Socioeconomicstatus
and incidence of Type 2 diabetes: Results from the Black Women’s HealthStudy.
American Journal of Epidemiology,171(5), 564-570. doi:10.1093aje/kwp443
Levey, A.S.,& Coresh, J. (2012). Chronic kidney disease. Lancet, 379(9811),165-180.
doi:10.1016.S0140-6736(11)60178-5.
Levey, A.S., Coresh, J., Balk, E., Kausz, A.T., Levin, A., Steffes, M.W.,...Eknoyan, G.
(2003). National kidney foundation practice guidelines for chronic kidney disease:
Evaluation, classification, and stratification. Annals of Internal Medicine, 139(2),
137-147.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V.,…Murray, C.
J. L.. (2010) Global and regional mortality from 235 causes of death for 20 age
groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease
Study. Lancet, 380(9859),2095-2128. doi:10.1016/S0140-6736(12)61728-0.
Macro Economy Meter. (2013). Diabetes prevalence- by country. Retrieved from
http://mecometer.com/topic/diabetes-prevalence.
Maher, D., Harries, A.D., Zachariah, R., &Enarson, D. (2009). A global framework for
action to improve the primary care response to chronic non-communicable
diseases: A solution to a neglected problem. BMC Public Health, 9(355), 1-7.
doi:10.1186/1471-2458-9-355.

86
Maric-Bilkan, C. (2017). Sex differences in micro- and macro-vascular complications of
diabetes mellitus. Clinical Science (London, England: 1979), 131(9), 833–846.
doi:10.1042/CS20160998.
Martínez-Maldonado, M. (1998). Hypertension in end-stage renal disease.Kidney
International, 54(Suppl. 68), S-67-S-72. doi:10.1046/j.1523-1755.1998.06816.x.
Mecometer (n.d.). Diabetes prevalence- Grenada. Retrieved from
http://mecometer.com/whats/grenada/diabetes-prevalence/
Mohammedi, K., Woodward, M., Marre, M., Colagiuri, S., Cooper, M., Harrap, S., ...
Chalmers, J. (2017). Comparative effects of microvascular and macrovascular
disease on the risk of major outcomes in patients with Type 2 diabetes.
Cardiovascular Diabetology, 16(95), 1-10. doi:10.1186/s12933-017-0574-y.
Moeller, S., Gioberge, S., & Brown, G. (2002). ESRD patients in 2001: Global overview
of patients, treatment modalities,and development trends. Nephrology Dialysis
Transplantation, 17(12), 2071-2076. doi:10.1093/ndt/17.12.2071.
Moor, V.J.A., Amougou, S.N., Ombotto, S., Ntone, F., Wouamba, D.E., &Nonga, B.N.
(2017). Dyslipidemia in patients with a cardiovascular risk and disease at the
University Teaching Hospital of Yaoundé, Cameroon. International Journal of
Vascular Medicine, 2017(6061306).doi:10.1155/2017/6061306.
Moore, D.J., Gregory, J.M., Kumah-Crystal, Y.A., & Simmons, J.H. (2009).
Mitigatingmicro-and macro-vascular complications of diabetes beginning in
adolescence.Vascular Health Risk Management, 5,1015-1031.
doi:10.2147/vhrm.s4891.

87
Murray, C.J.L., Lopez, A. D. (2000). The global burden disease in 1990: Final results and
their sensitivity to alternative epidemiological perspective, discount rates, ageweights and disability weights. World Health Organization, 247-294.
National Center for Biotechnology Information. (2018). How does the pancreas work?
Retrieved from https://emedicine.medscape.com/article/238798-overview.
National Institute of Diabetes and Digestive and Kidney Diseases. (2015). Mineral and
bone disorder in chronic kidney disease, Retrieved from
https://www.niddk.nih.gov/health-information/kidney-disease/chronickidneydisease-ckd/mineral-bone-disorder.
National Institute of Diabetes and Digestive and Kidney Diseases. (2016). Kidney disease
statisticsfor the United States. Retrieved from https://www.niddk.nih.gov/healthinformation/health-statistics/kidney-disease.
National Kidney Foundation. (2017). About chronic kidney disease. Retrieved from
www.kidney.org/atoz/contents/about-chronic-kidney-disease

Nicholas, S., Kalantar-Zadeh, K., & Norris, K. (2015). Socioeconomic disparities in
chronic kidney disease. Advances in Chronic Kidney Disease, 22(1), 6-15.
doi:10.1053/j.ackd.2014.07.002.
Oberg, E., Balentine, J.R., Cunha, J.P., &Shiel Jr., W.C. (2017). Type 2 diabetes
symptoms, signs, diet, and treatment. Retrieved from
https://www.medicinenet.com/type_2_diabetes/article.htm

88
Ontario Renal Network. (2016). The Ontario 2016 CKD system atlas – Trends in kidney
disease care.Retrieved from
http://www.renalnetwork.on.ca/common/pages/UserFile.aspx?fileId=362165
Ooi, Q. L, Tow, F K., Deva, R., Alias, M. A., Kawasaki, R., Wong, T. Y.,…Savige,
J.(2011). The microvasculature in chronic kidney disease. Clinical Journal of the
Society of Nephrology, 6(8), 1872-1878. doi:10.2215/CJN.10291110.
Patton, M.Q. (2008). Qualitative Research and Evaluation Methods (4th ed.).
ThousandOaks, CA: Sage.
Perel, P., Casas, J.P., Ortiz, Z., & Miranda, J.J. (2006). Noncommunicable diseases and
injuries in Latin America and the Caribbean: Time for action. PLOS Medicine,
3(9), 1448-1451. doi:10.1371/journal.pmed.0030344.
Polit, D. F.,& Beck, C.T. (2010). Generalization in quantitative and qualitative research:
Myths and strategies. International Journal of Nursing Studies,47(11), 14511458. doi:10.1016/j.ijnurstu.2010.06.004
Pradeep, A. M. (2020). Chronic kidney disease. Retrieved from
https://emedicine.medscape.com/article/238798-overview.
Pulgaron, E. R., & Delamater, A. M. (2018). Obesity and Type 2 diabetes in children:
Epidemiology and treatment. Current Diabetes Reports, 14(8), 508.
doi:10.1007/s11892-014-0508-y.
Ramteke, P., Deb, A., Shepal, V., & Bhat, M. K. (2019). Hyperglycemia associated
metabolic and molecular alterations in cancer risk, progression, treatment, and
mortality. Cancers, 11(9), 1402. doi:10.3390/cancers11091402.

89
Robbins, J.M., Vaccarino, V., Zhang, H., &Kasl, S.V. (2005). SES and
diagnoseddiabetes incidence, Diabetes Research and Clinical Practice, 68(3), 230
236. doi:10.1016/j.diabres.2004.09.007
Sato, K. K., Hayashi, T., Uehara, S., Kinuhata, S., Oue, K., Endo, G.,…Fukuda, K.
(2014). Kidney disease: The Kansai Healthcare Study. American Journal of
Nephrology, 40(6), 516-522. doi:10.1159/000370051
Schroeder, S.A. (2007). We can do better- improving the health of the American people.
New England Journal of Medicine, 357(12), 1221-1228.
Shaw, J.E., Sicree, R. A., &Zimmet, P. Z. (2010). Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Research and Clinical Practice,87(1), 4-14.
doi:10.1016/j.diabres.2009.10.007
Sherwani, S. I., Khan, H.A., Ekhzaimy, A., Masood, A., &Skharkar, M. K. (2016).
Significance of HbA1c test in diagnosis and prognosis of diabetic patients.
Biomarker Insights, 11, 95-104. doi:10.4137/BMI.S38440.
Skelly, A., Dougherty, M., Gesler, W., Soward, A., Burns, D., &Arcury, T. (2006).
AfricanAmerican beliefs about diabetes, Western Journal of Nursing Research,
28 (1), 9-28. doi:10.1177/0193945905280298.
Smart, N.A., Dieberg, G., Landhani, M., & Titus, T. (2014). Early referral to specialist
nephrology services to preventing the progression to end-stage kidney disease.
Cochrane Database of Systematic Reviews,
(6),doi:10.1002/14651858.cd007333.pub2

90
Soyibo, A. K., Roberts, L., & Barton, E. N. (2011). Chronic kidney disease in the
Caribbean. West Indian Medical Journal, 60(4),464-470.
Soyibo, A. K., & Barton, E. N. (2007). Report from the Caribbean renal registry, 2006.
Western Indian Medical Journal, 56(4), 355-363.
Stokols, D. (1996). Translating social, ecological theoryinto guidelines for community
health promotion. American Journal of Health Promotion, 10(4), 282-298.
doi:10.4278/0890-1171-10.4.282.
Sue-Hsien, C., Yun-Fang, T., Chiao-Yin, S., I-Wen, W., Chin-Chan, L., &Mai-Szu, W.
(2011). The impact of self-management support on the progression of chronic
kidney disease – A prospective randomized controlled trial. Nephrology Dialysis
Transplantation, 26(11), 2560-3566.doi:10.1093/ndt/gfr047
Taal, M. W., & Brenner, B. M. (2006). Predicting initiation and progression of chronic
kidney disease: Developing renal risk scores. Kidney International, 70(10), 16941705. doi:10.1038/sj.ki.5001794.
Tesfaye, S., Vileikyte, L., Rayman, G., Sindrup, S.H., Perkins, B.A., Baconja,
M.,…Boulton, A.J. (2011). Painful diabetic peripheral neuropathy: consensus
recommendations on diagnosis, assessment,and management. Diabetes
Metabolism Research and Review, 27(7), 629-638. doi:10.1002/dmrr.1225.
Thomas, R., Kanso, A., &Sedor, J. R. (2008). Chronic kidney disease and its
complications. Primary Care, 35(2),329. doi:10.1016/j.pop.2008.01.008.

91
Thorp, M.I., Eastman, L., Smith, D.H., & Johnson, E.S. (2006). Managing the burden of
chronic kidneydisease. Disease Management,9(2), 115-121.
doi:10.1089/dis.2006.9.115.
Tonelli, M., Wiebe, N., Culleton, B., House, A., Rabbat, C., Fok, M.,…Garg, A.X.
(2006). Chronic kidney disease and mortality risk: A systematic review. Journal
of the American Society of Nephrology, 17(7), 2034-2047.
doi:10.1681/ASN.2005101085.
United Nations International Children’s Emergency Fund. (2014). What are the social
ecological model (SEM) communication for development (C4D)? Retrieved from
https://www.unicef.org/cbsc/files/Module_1_-_MNCHN_C4D_Guide.docx
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2016). Chronic kidney
disease. The Lancet,389(10075), 1238-1252. doi:10.1016/S0140-6736(16)320645.
Whitaker, J. (2001). Reversing diabetes, New York, NY: Warner Brothers.
Wilcox, G. (2005). Insulin and insulin resistance. Clinical Biochemist Reviews, 26(2), 1939.
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of
diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care,
27(5),1047-1053.
Williams, D.R. & Jackson, P.B. (2005). Social sources of racial disparities in
health,Health Affairs, 24(2), 325-334. doi:10.1377/hlthaff.24.2.325.

92
World Health Organization. (2015). Grenada, country statistics. Retrieved from
http://www.who.int/countries/grd/en/.
World Health Organization (2017). Diabetes. Retrieved from
http://www.who.int/mediacentre/factsheets/fs312/en/.
World Health Organization. (2018).Obesity. Retrieved from
http://www.who.int/topics/obesity/en/.
Xu, J.Q., Murphy, S.L., Kochanek, K.D., &Bastain, B.A. (2013). Deaths: Final data for
2013. National Vital Statistics Report, 64(2),1-119. Retrieved from
https://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pdf.
Yiannakoulias, N. (2011). Understanding identifiability in secondary health
data.Canadian Journal of Public Health/Revue Canadienne de Sante'ePublique,
102(4),291-293.

